| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1B1 NAIP ATP9B ATP8B1 CLPX BPTF MYO3A ATP8A1 NAE1 MYO3B CHD6 KIF5A KIF5C ABCD2 DNAH5 DNAH6 HSPA9 DYNC1H1 MOV10 ATP8B3 APPBP2 EP400 NSF WRN IGHMBP2 UBA6 DHX34 ATP6V0A2 | 4.04e-08 | 614 | 278 | 28 | GO:0140657 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | HK1 MYLK NEK6 STK26 PBK CMPK2 PTK7 CDC7 ADK MYO3A PIK3C2G MYO3B SIK2 PKM KDR PARP9 DCLK2 NME7 MPP1 CDC42BPA CAMK2A POLB REV3L TEP1 STK31 CERT1 GRK1 TNNI3K CSF1R IKBKE CSNK1E DGKK UBA6 STKLD1 EPHB1 | 1.12e-07 | 938 | 278 | 35 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | HK1 MYLK NEK6 STK26 PBK CMPK2 PTK7 CDC7 ADK MYO3A PIK3C2G MYO3B SIK2 PKM KDR DCLK2 NME7 MPP1 CDC42BPA CAMK2A STK31 CERT1 GRK1 TNNI3K CSF1R IKBKE CSNK1E DGKK STKLD1 EPHB1 | 3.36e-07 | 764 | 278 | 30 | GO:0016301 |
| GeneOntologyMolecularFunction | magnesium ion binding | PDE2A IMPA1 NEK6 STK26 ATP9B HMGCL ATP8B1 FARSA ATP8A1 SIK2 PKM ATP8B3 CDC42BPA WRN ENO1 | 2.11e-06 | 247 | 278 | 15 | GO:0000287 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | HK1 MYLK NEK6 STK26 PBK PTK7 CDC7 ADK MYO3A PIK3C2G MYO3B SIK2 PKM KDR DCLK2 NME7 CDC42BPA CAMK2A STK31 GRK1 TNNI3K CSF1R IKBKE CSNK1E DGKK STKLD1 EPHB1 | 2.40e-06 | 709 | 278 | 27 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | HK1 MYLK NEK6 STK26 PBK PTK7 CDC7 MYO3A MYO3B SIK2 PKM KDR DCLK2 NME7 CDC42BPA CAMK2A STK31 GRK1 TNNI3K CSF1R IKBKE CSNK1E STKLD1 EPHB1 | 3.92e-06 | 600 | 278 | 24 | GO:0004672 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | NAIP ATP9B ATP8B1 CLPX ATP8A1 CHD6 KIF5A KIF5C ABCD2 DNAH5 DNAH6 HSPA9 DYNC1H1 MOV10 ATP8B3 NSF WRN IGHMBP2 DHX34 | 1.48e-05 | 441 | 278 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MYLK NEK6 STK26 PBK CDC7 MYO3A MYO3B SIK2 PKM DCLK2 CDC42BPA CAMK2A STK31 GRK1 TNNI3K IKBKE CSNK1E STKLD1 | 5.82e-05 | 446 | 278 | 18 | GO:0004674 |
| GeneOntologyMolecularFunction | 5'-3' RNA helicase activity | 1.93e-04 | 2 | 278 | 2 | GO:0032574 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 2.11e-04 | 9 | 278 | 3 | GO:0090556 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.49e-04 | 118 | 278 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | RIDA TRMT10B MRPL44 BPTF FARSA CHD6 TRMT61B NIPBL MOV10 DNMT3B RAG1 EP400 POLB WRN REV3L TEP1 YARS2 SLFN12L IGHMBP2 RCL1 DHX34 | 2.93e-04 | 645 | 278 | 21 | GO:0140640 |
| GeneOntologyMolecularFunction | calcium ion binding | MYL4 MATN2 ACTN4 ACTN1 CAPN8 COLEC11 FAT2 NRXN1 PLCZ1 FAT4 EFCAB6 PCDHGA10 CALU PCDHGA5 FAT3 CASQ1 GRM7 PPP3R1 EFHD1 ITSN2 PCDHGA8 CDH7 CDH13 | 3.49e-04 | 749 | 278 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.29e-04 | 70 | 278 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB1C NAIP ATP9B ATP8B1 CLPX GUF1 ATP8A1 CHD6 KIF5A KIF5C ABCD2 DNAH5 DNAH6 RAB26 HSPA9 DYNC1H1 MOV10 ATP8B3 NSF WRN RAB18 IGHMBP2 DHX34 | 5.59e-04 | 775 | 278 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 5.78e-04 | 28 | 278 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ACTN4 ACTN1 ITGA2 DSCAML1 NRXN1 PTPRZ1 PKM TLN2 KDR FLNA FLNB VWF APP CD9 TENM1 ARHGAP18 ENO1 CDH7 CDH13 | 7.75e-04 | 599 | 278 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | integrin binding | 7.96e-04 | 175 | 278 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | PDE2A IMPA1 STK26 ACTN4 ACTN1 DSCAML1 TXN PKM ABCD2 GPD1 RAG1 FLNA CAMK2A SYNE1 WRN PON2 XDH APP YARS2 CSF1R TENM1 CTBP1 ENO1 | 1.10e-03 | 815 | 278 | 23 | GO:0042803 |
| GeneOntologyMolecularFunction | ubiquitin activating enzyme activity | 1.14e-03 | 4 | 278 | 2 | GO:0004839 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | BPTF CHD6 NIPBL DNMT3B RAG1 EP400 POLB WRN REV3L TEP1 IGHMBP2 | 1.17e-03 | 262 | 278 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | floppase activity | 1.31e-03 | 16 | 278 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.32e-03 | 188 | 278 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.35e-03 | 227 | 278 | 10 | GO:0051015 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | GALNT1 NEK6 PBK CDC7 TXN MYO3A NRXN1 MYO3B PKD1 DCLK2 CAMK2A APP SLC1A1 AKAP9 IKBKE CSNK1E TENM1 | 1.56e-06 | 319 | 276 | 17 | GO:0018209 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | NEK6 PBK CDC7 TXN MYO3A NRXN1 MYO3B PKD1 DCLK2 CAMK2A APP SLC1A1 AKAP9 IKBKE CSNK1E TENM1 | 4.23e-06 | 307 | 276 | 16 | GO:0018105 |
| GeneOntologyBiologicalProcess | GMP metabolic process | 4.45e-06 | 33 | 276 | 6 | GO:0046037 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DSCAML1 PTK7 CD84 FAT2 PKD1 FAT4 PCDHGA10 PCDHGA5 FAT3 PCDHGA8 CDH7 CDH13 | 8.67e-06 | 187 | 276 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSCAML1 PTK7 CD84 FAT2 NRXN1 PKD1 GPC4 FAT4 PCDHGA10 PCDHGA5 FAT3 TENM1 PCDHGA8 CDH7 CDH13 | 2.27e-05 | 313 | 276 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | purine ribonucleoside monophosphate metabolic process | 4.16e-05 | 48 | 276 | 6 | GO:0009167 | |
| GeneOntologyBiologicalProcess | NMDA selective glutamate receptor signaling pathway | 4.60e-05 | 6 | 276 | 3 | GO:0098989 | |
| GeneOntologyBiologicalProcess | purine nucleoside monophosphate metabolic process | 5.91e-05 | 51 | 276 | 6 | GO:0009126 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HECW1 MATN2 ACTN1 DSCAML1 BAP1 PTK7 MYO3A NRXN1 PTPRZ1 GLI2 MYO3B KDR KIF5A KIF5C MOV10 FLNA FLNB SLC39A3 CAMK2A SYNE1 FAT3 APP CERT1 SHANK3 GRK1 CSF1R TIAM1 ITSN2 ARHGAP18 ZRANB1 CDH7 CDH13 EPHB1 | 6.39e-05 | 1194 | 276 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | ATP6V1B1 PDE2A HK1 ACACA IMPDH2 GART HMGCL CLPX NDUFS1 ADK SIK2 PKM NME7 MPP1 GPD1 XDH APP GDA ENO1 | 6.58e-05 | 512 | 276 | 19 | GO:0009150 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | ATP6V1B1 PDE2A HK1 ACACA IMPDH2 GART HMGCL CLPX PGD NDUFS1 ADK SIK2 PKM PARP9 NME7 MPP1 GPD1 XDH APP GDA ENO1 | 9.77e-05 | 619 | 276 | 21 | GO:0006163 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | MYLK NRXN1 GPC4 KIF5A KIF5C NME7 DNMT3B CAMK2A SYNE1 SLC1A1 CACNG8 PPP3R1 AKAP9 | 1.02e-04 | 278 | 276 | 13 | GO:0031503 |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | ATP6V1B1 PDE2A HK1 ACACA IMPDH2 GART HMGCL CLPX NDUFS1 ADK SIK2 PKM NME7 MPP1 GPD1 XDH APP GDA ENO1 | 1.11e-04 | 533 | 276 | 19 | GO:0009259 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | ATP6V1B1 PDE2A HK1 ACACA IMPDH2 GART HMGCL CLPX NDUFS1 ADK SIK2 PKM NME7 MPP1 GPD1 XDH APP GDA ENO1 | 1.32e-04 | 540 | 276 | 19 | GO:0019693 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.35e-04 | 59 | 276 | 6 | GO:0007215 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | ATP6V1B1 PDE2A HK1 ACACA IMPDH2 GART CMPK2 HMGCL CLPX PGD NDUFS1 ADK SIK2 PKM PARP9 NME7 MPP1 GPD1 XDH APP GDA ENO1 | 1.43e-04 | 684 | 276 | 22 | GO:0009117 |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | ATP6V1B1 PDE2A HK1 ACACA IMPDH2 GART CMPK2 HMGCL CLPX PGD NDUFS1 ADK SIK2 PKM PARP9 NME7 MPP1 GPD1 XDH APP GDA ENO1 | 1.66e-04 | 691 | 276 | 22 | GO:0006753 |
| GeneOntologyBiologicalProcess | guanylate kinase-associated protein clustering | 1.78e-04 | 2 | 276 | 2 | GO:0097117 | |
| GeneOntologyBiologicalProcess | nucleoside monophosphate metabolic process | 1.79e-04 | 88 | 276 | 7 | GO:0009123 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | ATP6V1B1 PDE2A HK1 ACACA IMPDH2 GART HMGCL CLPX PGD NDUFS1 ADK SIK2 PKM PARP9 NME7 MPP1 GPD1 XDH APP GDA ENO1 | 1.99e-04 | 652 | 276 | 21 | GO:0072521 |
| GeneOntologyBiologicalProcess | purine nucleobase metabolic process | 2.70e-04 | 24 | 276 | 4 | GO:0006144 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | ATP6V1B1 HK1 IMPDH2 CMPK2 CLPX NDUFS1 ADK SIK2 PKM NME7 GPD1 APP ENO1 | 2.71e-04 | 307 | 276 | 13 | GO:0009141 |
| GeneOntologyBiologicalProcess | ribonucleoside monophosphate metabolic process | 2.74e-04 | 67 | 276 | 6 | GO:0009161 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PDE2A IMPA1 CYP17A1 NAIP MPDZ ACTN1 PTK7 TXN BPTF NRXN1 PTPRZ1 SGCE KDR KIF5A KIF5C DYNC1H1 MAPK8IP1 FLNA FLNB NSF CAMK2A SYNE1 FAT3 DLGAP4 APP GRM7 ATXN1L SYAP1 SLC1A1 SHANK3 AKAP12 CACNG8 CSF1R AKAP9 TIAM1 CSNK1E ATP6AP2 IGHMBP2 SHARPIN SNCG EPHB1 | 5.02e-08 | 1228 | 278 | 41 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | PDE2A MPDZ ACTN1 TXN BPTF PTPRZ1 SGCE KIF5A KIF5C MAPK8IP1 FLNA NSF CAMK2A SYNE1 FAT3 DLGAP4 APP GRM7 ATXN1L SYAP1 SLC1A1 SHANK3 CACNG8 AKAP9 TIAM1 ATP6AP2 SHARPIN EPHB1 | 1.21e-05 | 858 | 278 | 28 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | PDE2A MPDZ ACTN1 TXN BPTF PTPRZ1 SGCE KIF5A KIF5C MAPK8IP1 FLNA NSF CAMK2A SYNE1 FAT3 DLGAP4 APP GRM7 ATXN1L SYAP1 SLC1A1 SHANK3 CACNG8 AKAP9 TIAM1 ATP6AP2 SHARPIN EPHB1 | 1.26e-05 | 860 | 278 | 28 | GO:0097447 |
| GeneOntologyCellularComponent | cell body | IMPA1 CYP17A1 NAIP PTK7 TXN BPTF NRXN1 PTPRZ1 KDR KIF5A KIF5C DYNC1H1 MAPK8IP1 FLNA FLNB CAMK2A DLGAP4 APP GRM7 SYAP1 SLC1A1 AKAP12 CSF1R AKAP9 TIAM1 CSNK1E ATP6AP2 IGHMBP2 SNCG | 1.92e-05 | 929 | 278 | 29 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | IMPA1 CYP17A1 NAIP PTK7 TXN NRXN1 PTPRZ1 KDR KIF5A KIF5C DYNC1H1 MAPK8IP1 FLNA FLNB CAMK2A DLGAP4 APP GRM7 SYAP1 SLC1A1 AKAP12 CSF1R AKAP9 TIAM1 CSNK1E IGHMBP2 SNCG | 2.05e-05 | 835 | 278 | 27 | GO:0043025 |
| GeneOntologyCellularComponent | axon | PDE2A IMPA1 CYP17A1 ITGA2 DSCAML1 PTK7 TXN NRXN1 PTPRZ1 SLC17A7 KIF5A KIF5C CNGA1 DYNC1H1 MAPK8IP1 FLNA CAMK2A APP GRM7 SYAP1 SLC1A1 TIAM1 CSNK1E ATP6AP2 IGHMBP2 SNCG ENO1 EPHB1 | 2.39e-05 | 891 | 278 | 28 | GO:0030424 |
| GeneOntologyCellularComponent | distal axon | ITGA2 NRXN1 PTPRZ1 KIF5A KIF5C CNGA1 MAPK8IP1 FLNA APP GRM7 SYAP1 SLC1A1 TIAM1 CSNK1E IGHMBP2 SNCG ENO1 | 7.97e-05 | 435 | 278 | 17 | GO:0150034 |
| GeneOntologyCellularComponent | growth cone | NRXN1 PTPRZ1 KIF5A KIF5C MAPK8IP1 FLNA APP SYAP1 TIAM1 CSNK1E IGHMBP2 ENO1 | 1.15e-04 | 245 | 278 | 12 | GO:0030426 |
| GeneOntologyCellularComponent | anchoring junction | MYLK MPDZ ACTN4 ACTN1 ITGA2 PTK7 FAT2 NRXN1 TLN2 KDR IQGAP3 HSPA9 MPP1 FLNA FLNB FLNC CDC42BPA MXRA8 APP PPIB AKAP12 CD9 TIAM1 RAI14 PATJ CDH7 CDH13 ATP6V0A2 | 1.16e-04 | 976 | 278 | 28 | GO:0070161 |
| GeneOntologyCellularComponent | site of polarized growth | NRXN1 PTPRZ1 KIF5A KIF5C MAPK8IP1 FLNA APP SYAP1 TIAM1 CSNK1E IGHMBP2 ENO1 | 1.56e-04 | 253 | 278 | 12 | GO:0030427 |
| GeneOntologyCellularComponent | axonal growth cone | 3.17e-04 | 45 | 278 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | cell cortex | ACTN4 ACTN1 IQGAP3 DYNC1H1 MPP1 FLNA FLNB GRM7 AKAP12 CLIP4 AKAP13 CTBP1 RAI14 ENO1 | 4.79e-04 | 371 | 278 | 14 | GO:0005938 |
| GeneOntologyCellularComponent | supramolecular fiber | IGFN1 MYL4 DCDC1 NEK6 NCKAP5 ACTN4 ACTN1 MYO3A KIF5A KIF5C NME7 DNAH5 DNAH6 LMNTD1 DYNC1H1 FLNA FLNB COL6A3 FLNC APPBP2 EFCAB6 EML4 POLB SYNE1 CASQ1 CLIP4 TIAM1 AKAP13 ARHGAP18 ENO1 | 5.13e-04 | 1179 | 278 | 30 | GO:0099512 |
| GeneOntologyCellularComponent | anchoring collagen complex | 5.24e-04 | 3 | 278 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | supramolecular polymer | IGFN1 MYL4 DCDC1 NEK6 NCKAP5 ACTN4 ACTN1 MYO3A KIF5A KIF5C NME7 DNAH5 DNAH6 LMNTD1 DYNC1H1 FLNA FLNB COL6A3 FLNC APPBP2 EFCAB6 EML4 POLB SYNE1 CASQ1 CLIP4 TIAM1 AKAP13 ARHGAP18 ENO1 | 5.72e-04 | 1187 | 278 | 30 | GO:0099081 |
| GeneOntologyCellularComponent | cell projection membrane | ATP8B1 SLC9C1 PTPRZ1 PKD1 SGCE CNGA1 MXRA8 PSD3 SLC34A3 SHANK3 CACNG8 TIAM1 BBS7 ATP6AP2 SPATA13 | 7.03e-04 | 431 | 278 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 7.60e-04 | 14 | 278 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | cilium | QRFPR SLC9C1 CFAP54 GLI2 MYO3B PKD1 PKM KIF5A KIF5C NME7 DNAH5 DNAH6 CNGA1 ERICH3 EFCAB6 TBC1D30 MXRA8 APP SLCO6A1 SHANK3 GRK1 AKAP9 TIAM1 BBS7 | 9.71e-04 | 898 | 278 | 24 | GO:0005929 |
| GeneOntologyCellularComponent | cell-cell junction | MYLK MPDZ ACTN4 ACTN1 PTK7 FAT2 NRXN1 TLN2 IQGAP3 MPP1 FLNA CDC42BPA MXRA8 APP TIAM1 PATJ CDH7 CDH13 | 1.01e-03 | 591 | 278 | 18 | GO:0005911 |
| GeneOntologyCellularComponent | collagen trimer | 1.14e-03 | 88 | 278 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | ciliary rootlet | 1.15e-03 | 16 | 278 | 3 | GO:0035253 | |
| GeneOntologyCellularComponent | filopodium | 1.31e-03 | 123 | 278 | 7 | GO:0030175 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PDE2A GALNT1 STK26 ATP9B ACTN4 ITGA2 HEPH BPTF KIF5A MAPK8IP1 FLNA PLCZ1 SYNE1 APP CERT1 PPIB SYAP1 IGHMBP2 TENM1 AKAP13 SNCG PATJ CDH13 ATP6V0A2 | 1.64e-03 | 934 | 278 | 24 | GO:0048471 |
| GeneOntologyCellularComponent | subapical complex | 1.72e-03 | 5 | 278 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | sarcomere | 1.92e-03 | 249 | 278 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.99e-03 | 98 | 278 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | focal adhesion | ACTN4 ACTN1 ITGA2 PTK7 TLN2 HSPA9 FLNA FLNB FLNC PPIB AKAP12 CD9 CDH13 ATP6V0A2 | 2.00e-03 | 431 | 278 | 14 | GO:0005925 |
| GeneOntologyCellularComponent | microtubule | DCDC1 NEK6 NCKAP5 KIF5A KIF5C NME7 DNAH5 DNAH6 DYNC1H1 APPBP2 EFCAB6 EML4 POLB CLIP4 TIAM1 ARHGAP18 | 2.19e-03 | 533 | 278 | 16 | GO:0005874 |
| GeneOntologyCellularComponent | filopodium tip | 2.24e-03 | 20 | 278 | 3 | GO:0032433 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 2.55e-03 | 6 | 278 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | cell-substrate junction | ACTN4 ACTN1 ITGA2 PTK7 TLN2 HSPA9 FLNA FLNB FLNC PPIB AKAP12 CD9 CDH13 ATP6V0A2 | 2.57e-03 | 443 | 278 | 14 | GO:0030055 |
| Domain | ACTININ_2 | 8.23e-07 | 23 | 277 | 6 | PS00020 | |
| Domain | ACTININ_1 | 8.23e-07 | 23 | 277 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.23e-07 | 23 | 277 | 6 | IPR001589 | |
| Domain | VWA | 1.62e-06 | 56 | 277 | 8 | PF00092 | |
| Domain | VWA | 4.25e-06 | 84 | 277 | 9 | SM00327 | |
| Domain | Cadherin | FREM1 FAT2 FAT4 PCDHGA10 PCDHGA5 FAT3 FREM3 PCDHGA8 CDH7 CDH13 | 1.04e-05 | 118 | 277 | 10 | IPR002126 |
| Domain | Prot_kinase_dom | MYLK NEK6 STK26 PBK PTK7 CDC7 MYO3A MYO3B SIK2 KDR DCLK2 CDC42BPA CAMK2A STK31 GRK1 TNNI3K CSF1R IKBKE CSNK1E STKLD1 EPHB1 | 1.41e-05 | 489 | 277 | 21 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MYLK NEK6 STK26 PBK PTK7 CDC7 MYO3A MYO3B SIK2 KDR DCLK2 CDC42BPA CAMK2A STK31 GRK1 TNNI3K CSF1R IKBKE CSNK1E STKLD1 EPHB1 | 1.59e-05 | 493 | 277 | 21 | PS50011 |
| Domain | VWF_A | 1.65e-05 | 99 | 277 | 9 | IPR002035 | |
| Domain | PROTEIN_KINASE_ATP | MYLK NEK6 STK26 PBK CDC7 MYO3A MYO3B SIK2 KDR DCLK2 CDC42BPA CAMK2A STK31 GRK1 TNNI3K CSF1R IKBKE CSNK1E STKLD1 EPHB1 | 1.84e-05 | 459 | 277 | 20 | PS00107 |
| Domain | Kinase-like_dom | MYLK NEK6 STK26 PBK PTK7 CDC7 MYO3A PIK3C2G MYO3B SIK2 KDR DCLK2 CDC42BPA CAMK2A STK31 GRK1 TNNI3K CSF1R IKBKE CSNK1E STKLD1 EPHB1 | 2.09e-05 | 542 | 277 | 22 | IPR011009 |
| Domain | Laminin_G | 2.31e-05 | 58 | 277 | 7 | IPR001791 | |
| Domain | VWFA | 2.92e-05 | 82 | 277 | 8 | PS50234 | |
| Domain | P_typ_ATPase_c | 4.22e-05 | 14 | 277 | 4 | IPR032630 | |
| Domain | P-type_ATPase_N | 4.22e-05 | 14 | 277 | 4 | IPR032631 | |
| Domain | PhoLip_ATPase_C | 4.22e-05 | 14 | 277 | 4 | PF16212 | |
| Domain | PhoLip_ATPase_N | 4.22e-05 | 14 | 277 | 4 | PF16209 | |
| Domain | P-type_ATPase_IV | 4.22e-05 | 14 | 277 | 4 | IPR006539 | |
| Domain | CH | 4.89e-05 | 65 | 277 | 7 | SM00033 | |
| Domain | Protein_kinase_ATP_BS | MYLK NEK6 STK26 CDC7 MYO3A MYO3B SIK2 KDR DCLK2 CDC42BPA CAMK2A GRK1 TNNI3K CSF1R IKBKE CSNK1E EPHB1 | 5.50e-05 | 379 | 277 | 17 | IPR017441 |
| Domain | CH | 7.90e-05 | 70 | 277 | 7 | PF00307 | |
| Domain | - | 8.65e-05 | 71 | 277 | 7 | 1.10.418.10 | |
| Domain | CH | 1.03e-04 | 73 | 277 | 7 | PS50021 | |
| Domain | PROTEIN_KINASE_ST | MYLK NEK6 STK26 PBK CDC7 MYO3A MYO3B SIK2 DCLK2 CDC42BPA CAMK2A STK31 GRK1 TNNI3K IKBKE CSNK1E | 1.08e-04 | 362 | 277 | 16 | PS00108 |
| Domain | - | 1.13e-04 | 74 | 277 | 7 | 3.40.50.410 | |
| Domain | CH-domain | 1.23e-04 | 75 | 277 | 7 | IPR001715 | |
| Domain | Pkinase | MYLK NEK6 STK26 PBK CDC7 MYO3A MYO3B SIK2 DCLK2 CDC42BPA CAMK2A STK31 GRK1 IKBKE CSNK1E STKLD1 | 1.94e-04 | 381 | 277 | 16 | PF00069 |
| Domain | L27_2 | 2.19e-04 | 2 | 277 | 2 | PF09045 | |
| Domain | L27_2 | 2.19e-04 | 2 | 277 | 2 | IPR015132 | |
| Domain | Cadherin_CS | 2.21e-04 | 109 | 277 | 8 | IPR020894 | |
| Domain | CADHERIN_1 | 2.82e-04 | 113 | 277 | 8 | PS00232 | |
| Domain | Cadherin | 2.82e-04 | 113 | 277 | 8 | PF00028 | |
| Domain | - | 3.00e-04 | 114 | 277 | 8 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 3.00e-04 | 114 | 277 | 8 | PS50268 | |
| Domain | Ser/Thr_kinase_AS | MYLK NEK6 PBK CDC7 MYO3A MYO3B SIK2 DCLK2 CDC42BPA CAMK2A STK31 GRK1 TNNI3K IKBKE CSNK1E | 3.04e-04 | 357 | 277 | 15 | IPR008271 |
| Domain | CA | 3.18e-04 | 115 | 277 | 8 | SM00112 | |
| Domain | Cadherin-like | 3.37e-04 | 116 | 277 | 8 | IPR015919 | |
| Domain | IG_FLMN | 3.58e-04 | 10 | 277 | 3 | SM00557 | |
| Domain | ConA-like_dom | TRIM26 FAT2 NRXN1 PTX3 SEL1L3 COL14A1 FAT4 COL12A1 COL20A1 FAT3 LGALS7 | 4.46e-04 | 219 | 277 | 11 | IPR013320 |
| Domain | FN3 | IGFN1 MYLK DSCAML1 PTPRZ1 COL14A1 COL6A3 FLNC COL12A1 COL20A1 EPHB1 | 4.55e-04 | 185 | 277 | 10 | SM00060 |
| Domain | Filamin | 4.88e-04 | 11 | 277 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 4.88e-04 | 11 | 277 | 3 | PS50194 | |
| Domain | Filamin/ABP280_repeat-like | 4.88e-04 | 11 | 277 | 3 | IPR017868 | |
| Domain | Filamin/ABP280_rpt | 4.88e-04 | 11 | 277 | 3 | IPR001298 | |
| Domain | - | 5.32e-04 | 95 | 277 | 7 | 2.60.120.200 | |
| Domain | Beta-propeller_rpt_TECPR | 6.51e-04 | 3 | 277 | 2 | IPR006624 | |
| Domain | TECPR | 6.51e-04 | 3 | 277 | 2 | SM00706 | |
| Domain | P-loop_NTPase | ATP6V1B1 NAIP CMPK2 CLPX NDST3 GUF1 MYO3A MYO3B CHD6 KIF5A KIF5C ABCD2 DNAH5 DNAH6 RAB26 DYNC1H1 MOV10 MPP1 EP400 NSF WRN TEP1 RAB18 IGHMBP2 DHX34 | 8.80e-04 | 848 | 277 | 25 | IPR027417 |
| Domain | - | 9.66e-04 | 169 | 277 | 9 | 3.40.50.720 | |
| Domain | S_TKc | MYLK NEK6 STK26 PBK CDC7 MYO3A MYO3B SIK2 DCLK2 CDC42BPA CAMK2A STK31 GRK1 IKBKE | 9.93e-04 | 359 | 277 | 14 | SM00220 |
| Domain | ATPase_dyneun-rel_AAA | 1.04e-03 | 14 | 277 | 3 | IPR011704 | |
| Domain | MT | 1.04e-03 | 14 | 277 | 3 | PF12777 | |
| Domain | AAA_8 | 1.04e-03 | 14 | 277 | 3 | PF12780 | |
| Domain | AAA_5 | 1.04e-03 | 14 | 277 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.04e-03 | 14 | 277 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.04e-03 | 14 | 277 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.04e-03 | 14 | 277 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.04e-03 | 14 | 277 | 3 | PF08393 | |
| Domain | NAD(P)-bd_dom | 1.14e-03 | 173 | 277 | 9 | IPR016040 | |
| Domain | FN3_dom | IGFN1 MYLK DSCAML1 PTPRZ1 COL14A1 COL6A3 FLNC COL12A1 COL20A1 EPHB1 | 1.16e-03 | 209 | 277 | 10 | IPR003961 |
| Domain | - | 1.23e-03 | 32 | 277 | 4 | 3.40.1110.10 | |
| Domain | - | 1.23e-03 | 32 | 277 | 4 | 2.70.150.10 | |
| Domain | DHC_fam | 1.29e-03 | 15 | 277 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.29e-03 | 15 | 277 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.29e-03 | 15 | 277 | 3 | IPR004273 | |
| Domain | FERM_f0 | 1.29e-03 | 4 | 277 | 2 | PF16511 | |
| Domain | FERM_f0 | 1.29e-03 | 4 | 277 | 2 | IPR032425 | |
| Domain | AAA+_ATPase | 1.40e-03 | 144 | 277 | 8 | IPR003593 | |
| Domain | AAA | 1.40e-03 | 144 | 277 | 8 | SM00382 | |
| Domain | Collagen | 1.66e-03 | 85 | 277 | 6 | IPR008160 | |
| Domain | Collagen | 1.66e-03 | 85 | 277 | 6 | PF01391 | |
| Domain | ATPase_P-typ_cyto_domN | 1.73e-03 | 35 | 277 | 4 | IPR023299 | |
| Domain | - | MYL4 ACTN4 ACTN1 CAPN8 PLCZ1 EFCAB6 CALU TBC1D8 PPP3R1 EFHD1 ITSN2 | 1.86e-03 | 261 | 277 | 11 | 1.10.238.10 |
| Domain | ATPase_P-typ_P_site | 1.92e-03 | 36 | 277 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.92e-03 | 36 | 277 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.92e-03 | 36 | 277 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.13e-03 | 37 | 277 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.13e-03 | 37 | 277 | 4 | PF00122 | |
| Domain | RII_binding_1 | 2.13e-03 | 5 | 277 | 2 | PF10522 | |
| Domain | 2FE2S_FER_1 | 2.13e-03 | 5 | 277 | 2 | PS00197 | |
| Domain | 2Fe2S_fd_BS | 2.13e-03 | 5 | 277 | 2 | IPR006058 | |
| Domain | RII_binding_1 | 2.13e-03 | 5 | 277 | 2 | IPR018459 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 7.29e-06 | 86 | 219 | 9 | M39375 | |
| Pathway | WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER | 4.32e-05 | 42 | 219 | 6 | M39740 | |
| Pathway | KEGG_FOCAL_ADHESION | MYLK ACTN4 ACTN1 ITGA2 TLN2 KDR DOCK1 FLNA FLNB COL6A3 FLNC VWF | 6.56e-05 | 199 | 219 | 12 | M7253 |
| Pubmed | HK1 IMPDH2 MRPL44 MPDZ CLPX PGD NDUFS1 PTK7 NSDHL TXN PLEKHG1 GUF1 NAE1 SIK2 PRPF19 COL14A1 HERC2 NME7 NENF HSPA9 CDC42BPA NSF ANP32B CALU SYNE1 PSD3 ANKRD26 PON2 SHMT2 APP ECH1 PPIB AKAP12 TBC1D8 AKAP9 MRPL15 TIAM1 BBS7 CSNK1E ATP6AP2 RCL1 UBA6 CNDP2 AKAP13 ATP6V0A2 | 2.00e-14 | 1487 | 280 | 45 | 33957083 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK1 ACACA IMPDH2 MRPL44 GART ACTN4 HMGCL CLPX PGD NDUFS1 NSDHL TXN FARSA PKM PRPF19 TLN2 DNAH5 NIPBL IQGAP3 HSPA9 DYNC1H1 FLNA FLNB PSAT1 NSF ANP32B CALU NPEPPS SYNE1 CHAF1A PHF6 SHMT2 PPIB SYAP1 YARS2 GBA3 CSNK1E FANCI RCL1 UBA6 SPEN ENO1 | 3.94e-13 | 1425 | 280 | 42 | 30948266 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HK1 ACACA IMPDH2 STK26 GART MPDZ ACTN4 ACTN1 PGD BAP1 MSI2 TXN NAE1 PKM PRPF19 IQGAP3 HSPA9 DYNC1H1 MOV10 FLNA FLNB FLNC PSAT1 NSF ANP32B CALU NPEPPS SHMT2 PPIB SYAP1 AKAP12 FANCI RAI14 TRAPPC3 PATJ ENO1 ALDH7A1 | 8.71e-13 | 1149 | 280 | 37 | 35446349 |
| Pubmed | HK1 MYLK ACTN4 HMGCL ACTN1 CLPX NDUFS1 PTK7 BPTF NRXN1 GPC4 PKM PRPF19 KDR CHD6 KIF5A KIF5C USP1 DNAH6 NIPBL HSPA9 DNMT3B FLNA FLNB FLNC COL20A1 PCDHGA10 PCDHGA5 SYNE1 CHAF1A ANKRD26 VPS36 STK31 PPIB DGKK ITSN2 TENM1 SPEN ENO1 PCDHGA8 SPATA13 | 2.43e-12 | 1442 | 280 | 41 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK1 ACACA IMPDH2 GART ACTN4 ACTN1 CLPX PGD NDUFS1 TXN GUF1 PKM PRPF19 HERC2 NME7 NIPBL HSPA9 DYNC1H1 MOV10 FLNA FLNB FLNC TCF20 EP400 EML4 NPEPPS PHF6 SHMT2 ECH1 PPIB LGALS7 MEMO1 FANCI RCL1 AKAP13 RAI14 ENO1 DHX34 ALDH7A1 | 5.88e-12 | 1353 | 280 | 39 | 29467282 |
| Pubmed | PDE2A HK1 STK26 ACTN4 ACTN1 ITGA2 NDUFS1 TXN FARSA ATP8A1 PTPRZ1 PKM SLC17A7 PRPF19 TLN2 DCLK2 KIF5C DNAH6 HSDL1 HSPA9 DYNC1H1 MAPK8IP1 FLNA FLNB FLNC VWF NSF CAMK2A NPEPPS SYNE1 DLGAP4 PSD3 PPIB SHANK3 GDA ITSN2 CTBP1 RAI14 TRAPPC3 ALDH7A1 | 7.84e-12 | 1431 | 280 | 40 | 37142655 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HK1 ACACA GART ACTN4 ACTN1 PGD NSDHL TXN ADK GUF1 PKM PRPF19 IQGAP3 DYNC1H1 FLNA FLNB FLNC ANP32B NPEPPS SYNE1 SHMT2 ECH1 PPIB RAB18 AKAP9 CNDP2 AKAP13 ARHGAP18 ENO1 | 2.34e-11 | 807 | 280 | 29 | 30575818 |
| Pubmed | PDE2A IMPDH2 HECW1 MPDZ ARMCX4 FARSA NRXN1 TLN2 KIF5A KIF5C HERC2 NIPBL HSPA9 DYNC1H1 MAPK8IP1 TCF20 NSF CAMK2A NPEPPS SYNE1 DLGAP4 PPIB SHANK3 AKAP12 GDA AKAP9 UBA6 CTBP1 TRAPPC3 ENO1 SPATA13 | 7.20e-11 | 963 | 280 | 31 | 28671696 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NEK6 ACACA TRIM26 NAIP ATP9B ATP8B1 SLC10A7 PTK7 MSI2 BPTF TECPR2 GLI2 TGFBRAP1 SEL1L3 DCLK2 CHD6 KIF5C DOCK1 FLNB PSAT1 CDC42BPA NPEPPS PON2 PHF6 APP TEP1 ECH1 CERT1 SLC1A1 EFHD1 UBA6 CNDP2 RCOR3 AKAP13 CTBP1 RAI14 PATJ NFAT5 ZRANB1 | 1.00e-10 | 1489 | 280 | 39 | 28611215 |
| Pubmed | IMPA1 ACACA IMPDH2 MATN2 STK26 GART ACTN4 PSME2 NDUFS1 TXN FARSA PKM PRPF19 HSPA9 DYNC1H1 FLNA PSAT1 CDC42BPA NSF CALU NPEPPS PHF6 SHMT2 APP RAB18 AKAP9 CSNK1E IGHMBP2 CNDP2 RCOR3 CTBP1 RAI14 PATJ NFAT5 ENO1 | 1.63e-10 | 1247 | 280 | 35 | 27684187 | |
| Pubmed | KCNH7 IMPA1 ACACA HECW1 RAB1C ACTN4 HMGCL NDUFS1 PTK7 TXN NRXN1 PKM TLN2 DCLK2 HSPA9 MAPK8IP1 FLNA FLNB CDC42BPA CAMK2A DLGAP4 ATG2B PSD3 APP SHANK3 CACNG8 PPP3R1 CSNK1E IGHMBP2 TENM1 CNDP2 TRAPPC3 ENO1 | 2.54e-10 | 1139 | 280 | 33 | 36417873 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RIDA ATP6V1B1 ACTN1 PSME2 PGD TXN PKD1 PKM NIPBL DYNC1H1 GPD1 FLNA FLNB COL6A3 PSAT1 VWF CDC42BPA NPEPPS MXRA8 SHMT2 VPS36 PPIB SLC1A1 CRYZ CD9 ATP6AP2 ITSN2 CNDP2 SNCG PATJ SPEN | 2.67e-10 | 1016 | 280 | 31 | 19056867 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 HK1 ACACA IMPDH2 C9orf78 STK26 GART ACTN4 ACTN1 PSME2 PGD TXN FARSA NAE1 PKM PRPF19 HSPA9 DYNC1H1 FLNA FLNB FLNC PSAT1 ANP32B CALU NPEPPS SHMT2 VPS36 CERT1 PPIB AKAP12 GDA CRYZ FANCI UBA6 CNDP2 HERC4 ALDH7A1 | 7.14e-10 | 1455 | 280 | 37 | 22863883 |
| Pubmed | ACTN4 NDUFS1 MED12L PKM COL14A1 USP1 HSPA9 GPD1 FLNB COL6A3 FLNC COL12A1 VWF CDC42BPA SYNE1 ANKRD26 AKAP12 CLIP4 AKAP9 RCOR3 ENO1 | 8.73e-10 | 497 | 280 | 21 | 23414517 | |
| Pubmed | USP34 PDE2A NCKAP5 ACTN4 ACTN1 ARMCX4 DSCAML1 GUF1 PKD1 PKM TLN2 DCLK2 CHD6 KIF5A KIF5C HERC2 NIPBL HSPA9 DYNC1H1 MAPK8IP1 FLNB VWF CAMK2A SYNE1 REV3L APP RUFY2 CLIP4 PPP3R1 TIAM1 WIF1 SHARPIN CTBP1 RAI14 | 1.38e-09 | 1285 | 280 | 34 | 35914814 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ACACA IMPDH2 GART ACTN4 NDUFS1 SBSN TXN PKM HSPA9 DYNC1H1 MOV10 FLNA FLNB FLNC PSAT1 NPEPPS PPIB LGALS7 RAI14 ENO1 | 2.54e-09 | 477 | 280 | 20 | 31300519 |
| Pubmed | ACACA ATP9B FREM1 FAT2 HSPA9 TCF20 SYNE1 DLGAP4 CASQ1 REV3L AKAP9 FANCI | 4.38e-09 | 152 | 280 | 12 | 34299191 | |
| Pubmed | HK1 ACTN4 ACTN1 PGD MYO3B PKM HSPA9 FLNA FLNB FLNC ANP32B ENO1 | 4.72e-09 | 153 | 280 | 12 | 27462432 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | NEK6 ACACA IMPDH2 MRPL44 GART CLPX MYCBPAP TXN NAE1 PRPF19 KIF5C HERC2 HSDL1 DYNC1H1 MOV10 NSF EML4 CAMK2A NPEPPS CHAF1A PON2 SHMT2 PPIB YARS2 TIAM1 IKBKE CSNK1E EFHD1 FANCI AKAP13 RAI14 SNCG NACA4P | 5.01e-09 | 1284 | 280 | 33 | 17353931 |
| Pubmed | IMPDH2 ACTN4 ACTN1 PKM HSPA9 DYNC1H1 FLNA FLNB FLNC PSAT1 ECH1 RAI14 ENO1 | 6.01e-09 | 191 | 280 | 13 | 33762435 | |
| Pubmed | HK1 GART ACTN4 ACTN1 CLPX NDUFS1 NSDHL PKM HSPA9 DYNC1H1 FLNA FLNC NSF RAI14 NFAT5 ENO1 | 6.30e-09 | 312 | 280 | 16 | 37120454 | |
| Pubmed | ACACA IMPDH2 GART GOLM1 ACTN4 PSME2 CLPX PGD NDUFS1 NSDHL TXN BPTF PRPF19 NIPBL NENF HSPA9 DYNC1H1 FLNA FLNB COL12A1 CALU PON2 PHF6 APP AKAP12 GDA RAB18 MRPL15 ATP6AP2 AKAP13 RAI14 HERC4 ALDH7A1 | 6.39e-09 | 1297 | 280 | 33 | 33545068 | |
| Pubmed | PLEKHG1 SEL1L3 CHD6 DYNC1H1 APPBP2 TCF20 EP400 CAMK2A SYNE1 DLGAP4 PSD3 PHF6 AKAP9 ITSN2 ASB1 SPEN NFAT5 SPATA13 | 7.14e-09 | 407 | 280 | 18 | 12693553 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PDE2A HK1 RAB1C NAIP ACTN1 NDUFS1 ATP8A1 PKM KIF5C HSPA9 DYNC1H1 GPD1 NSF CAMK2A NPEPPS PPIB GDA CD9 EFHD1 CTBP1 ENO1 ATP6V0A2 | 8.65e-09 | 621 | 280 | 22 | 22794259 |
| Pubmed | IMPDH2 TRIM26 MPDZ ACTN1 NDUFS1 TXN GUF1 FARSA BRD8 CHD6 HERC2 NIPBL IQGAP3 MOV10 CDC42BPA TBC1D30 EP400 NSF SYNE1 CHAF1A WRN PHF6 APP RAB18 EFHD1 ATP6AP2 IGHMBP2 ITSN2 RCL1 CTBP1 RAI14 KDM1B PATJ SPEN ATP6V0A2 | 1.80e-08 | 1497 | 280 | 35 | 31527615 | |
| Pubmed | IMPDH2 GART MPDZ FARSA PKM HSPA9 DYNC1H1 DOCK1 FLNB CDC42BPA NSF ATG2B PSD3 ANKRD26 PPIB SYAP1 AKAP12 TBC1D8 FANCI UBA6 RAI14 PATJ ENO1 | 1.95e-08 | 708 | 280 | 23 | 39231216 | |
| Pubmed | USP34 HK1 ACACA IMPDH2 GART ACTN4 ACTN1 NDUFS1 BPTF HERC2 NIPBL HSPA9 DYNC1H1 MOV10 FLNA FLNB FLNC TCF20 NPEPPS FANCI RCL1 SPEN | 2.12e-08 | 653 | 280 | 22 | 22586326 | |
| Pubmed | HK1 ACACA EMILIN3 FREM1 TECPR2 TGFBRAP1 GPC4 TRMT61B DOCK1 FLNA FLNC NSF NPEPPS ATG2B SHMT2 LGALS7 FANCI ALDH7A1 | 2.13e-08 | 437 | 280 | 18 | 20562859 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | HK1 ACACA IMPDH2 GART ACTN4 ACTN1 PSME2 CLPX PGD NSDHL NAE1 PKM PARP9 NME7 HSPA9 FLNA FLNB FLNC NSF CALU NPEPPS PHF6 SHMT2 PPIB AKAP12 YARS2 CRYZ RCL1 UBA6 RAI14 TRAPPC3 ENO1 ALDH7A1 | 2.25e-08 | 1367 | 280 | 33 | 32687490 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | HK1 ACTN4 ACTN1 PGD CDC7 PLEKHG1 PKD1 GPC4 PKM IQGAP3 HSPA9 FLNA FLNB FLNC EP400 CALU ECH1 SHANK3 PPP3R1 ENO1 | 4.13e-08 | 564 | 280 | 20 | 21565611 |
| Pubmed | RIDA IMPDH2 GART ACTN4 PGD TXN PKM HSPA9 DYNC1H1 FLNA PSAT1 ANP32B NPEPPS SHMT2 ECH1 PPIB CRYZ CNDP2 ENO1 EPHB1 | 4.25e-08 | 565 | 280 | 20 | 20458337 | |
| Pubmed | KCNH7 ACTN4 PGD NDUFS1 PKM PRPF19 L3HYPDH HERC2 HSPA9 DSE COL6A3 FAT4 CALU ATG2B CERT1 ATP6AP2 TENM1 RCOR3 ENO1 | 4.61e-08 | 513 | 280 | 19 | 25798074 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ACACA IMPDH2 C9orf78 GART PBK ACTN4 ACTN1 PSME2 CLPX MSI2 TXN FARSA PKM PRPF19 NIPBL HSPA9 DYNC1H1 FLNA FLNB EML4 ANP32B SHMT2 ECH1 PPIB LGALS7 YARS2 MEMO1 GDA RAB18 UBA6 AKAP13 TRAPPC3 ENO1 | 5.06e-08 | 1415 | 280 | 33 | 28515276 |
| Pubmed | ATP6V1B1 IMPDH2 STK26 GART PGD NDUFS1 NSDHL TXN ADK NAE1 PKM HSPA9 DYNC1H1 FLNA FLNB PSAT1 NSF CALU NPEPPS SHMT2 AKAP12 FANCI CNDP2 CTBP1 ENO1 | 5.99e-08 | 878 | 280 | 25 | 37223481 | |
| Pubmed | KCNH7 MYLK RAB1C NCKAP5 PKD1 DOCK1 RAG1 FLNA FLNB FLNC CHAF1A DLGAP4 TDRD1 SHANK3 SPEN | 8.84e-08 | 329 | 280 | 15 | 17474147 | |
| Pubmed | IMPDH2 ACTN4 ACTN1 PSME2 CAPN8 NAE1 PKM HSPA9 DYNC1H1 MOV10 FLNA FLNB PSAT1 CDC42BPA CHAF1A DLGAP4 PPP3R1 CNDP2 ENO1 | 9.67e-08 | 538 | 280 | 19 | 28524877 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYL4 ACACA IMPDH2 GART CLPX NDUFS1 BAP1 NSDHL GUF1 FARSA PKM PRPF19 CHD6 NIPBL HSPA9 DYNC1H1 MOV10 MPP1 FLNA EP400 NSF CHAF1A WRN PHF6 SHMT2 ECH1 PPIB RCL1 CNDP2 CTBP1 ENO1 | 1.10e-07 | 1318 | 280 | 31 | 30463901 |
| Pubmed | 1.30e-07 | 30 | 280 | 6 | 16027165 | ||
| Pubmed | 1.31e-07 | 49 | 280 | 7 | 21362503 | ||
| Pubmed | IMPDH2 C9orf78 GART MPDZ CLPX SBSN PLEKHG1 FARSA DOCK1 CDC42BPA CALU PHF6 SHMT2 ECH1 PPIB LGALS7 TIAM1 CSNK1E FANCI ITSN2 RCL1 AKAP13 ARHGAP18 PATJ SPATA13 | 1.33e-07 | 916 | 280 | 25 | 32203420 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | IMPDH2 ACTN4 CLPX PKM HSPA9 DYNC1H1 MOV10 MPP1 FLNA FLNB FLNC NPEPPS XDH CNDP2 ENO1 | 1.57e-07 | 344 | 280 | 15 | 30333137 |
| Pubmed | HK1 IMPDH2 ACTN4 HMGCL ACTN1 PGD NDUFS1 NSDHL TXN PKM RAB26 NENF HSPA9 HSD17B7 CALU NPEPPS PON2 SHMT2 APP ECH1 YARS2 CRYZ ENO1 ALDH7A1 | 1.57e-07 | 859 | 280 | 24 | 31536960 | |
| Pubmed | HK1 IMPDH2 ACTN1 PGD TXN PKM HSPA9 DYNC1H1 FLNA FLNB FLNC PSAT1 NPEPPS PPIB LGALS7 ENO1 | 1.76e-07 | 397 | 280 | 16 | 21319273 | |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 2.38e-07 | 141 | 280 | 10 | 32322062 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HK1 IMPDH2 MRPL44 NDUFS1 NSDHL BPTF FARSA NRXN1 GPC4 PKM PRPF19 CHD6 NIPBL HSDL1 DYNC1H1 DNMT3B FLNC CDC42BPA TCF20 EP400 SYNE1 SHMT2 PPIB RCL1 CTBP1 KDM1B SPEN | 2.44e-07 | 1082 | 280 | 27 | 38697112 |
| Pubmed | GART NDUFS1 BPTF PKM TRMT61B NIPBL HSPA9 DYNC1H1 TCAF2 FLNA FLNB FLNC VWF AKAP12 CNDP2 | 2.81e-07 | 360 | 280 | 15 | 33111431 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | USP34 GALNT1 ACACA MATN2 MRPL44 GART RAB1C ACTN4 HMGCL CLPX NDUFS1 SBSN PTK7 NSDHL TXN GUF1 PKM DNAH6 HSPA9 FLNA FLNB FLNC HSD17B7 NSF CALU MXRA8 SHMT2 PPIB YARS2 RAB18 AKAP9 CTBP1 | 2.85e-07 | 1451 | 280 | 32 | 30550785 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IMPDH2 GART ACTN4 ACTN1 BPTF PKM PRPF19 HERC2 NIPBL HSPA9 DYNC1H1 FLNA FLNB FLNC TCF20 EP400 NSF NPEPPS SYNE1 SHMT2 APP PPIB BBS7 UBA6 SPEN ENO1 | 2.97e-07 | 1024 | 280 | 26 | 24711643 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | IMPDH2 ACTN4 ACTN1 PGD MSI2 TXN FARSA PKM PRPF19 HSPA9 DYNC1H1 MOV10 FLNA PSAT1 NSF CALU SYNE1 SHMT2 ECH1 PPIB ENO1 | 4.22e-07 | 714 | 280 | 21 | 28302793 |
| Pubmed | IMPDH2 GART ACTN4 ACTN1 PSME2 CLPX NDUFS1 SBSN TXN MYO3A FARSA PKM HSPA9 DYNC1H1 FLNA FLNB FLNC CALU SYNE1 PPIB LGALS7 GDA ENO1 | 4.44e-07 | 844 | 280 | 23 | 25963833 | |
| Pubmed | BCL2L14 GUF1 FARSA TGFBRAP1 PKM CHD6 DNAH5 FLNA FLNB CD9 ARHGAP18 PATJ ENO1 | 4.66e-07 | 277 | 280 | 13 | 30745168 | |
| Pubmed | 5.16e-07 | 3 | 280 | 3 | 17173071 | ||
| Pubmed | 5.16e-07 | 3 | 280 | 3 | 12393796 | ||
| Pubmed | 5.16e-07 | 3 | 280 | 3 | 11153914 | ||
| Pubmed | 5.16e-07 | 3 | 280 | 3 | 11252955 | ||
| Pubmed | NCKAP5 ACTN4 ACTN1 MSI2 CHD6 KIF5A HERC2 DOCK1 FLNA FLNC VWF CDC42BPA TCF20 SYNE1 CHAF1A ITSN2 AKAP13 | 5.29e-07 | 486 | 280 | 17 | 20936779 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | ACACA IMPDH2 GART ACTN4 ACTN1 TXN PKM HSPA9 DYNC1H1 FLNA PSAT1 FANCI ENO1 | 5.48e-07 | 281 | 280 | 13 | 30455355 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ACACA IMPDH2 ACTN1 SBSN TXN BPTF PKM PRPF19 NENF HSPA9 FLNA FLNB FLNC TCF20 ANP32B CALU CHAF1A PHF6 SHMT2 LGALS7 YARS2 RAB18 FANCI RCL1 ENO1 | 5.51e-07 | 989 | 280 | 25 | 36424410 |
| Pubmed | Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function. | 5.98e-07 | 21 | 280 | 5 | 16196101 | |
| Pubmed | BCL2L14 HK1 GALNT1 MYLK HECW1 PSME2 BAP1 CAPN8 ATP8A1 DNAH5 ATP8B3 PLCZ1 CDC42BPA SHMT2 PPIB GRK1 CSNK1E DGKK UBA6 KDM1B ATP6V0A2 | 6.04e-07 | 730 | 280 | 21 | 34857952 | |
| Pubmed | ACTN4 ACTN1 ITGA2 PTK7 TLN2 HSPA9 FLNA FLNB FLNC PPIB AKAP12 CD9 CDH13 | 6.43e-07 | 285 | 280 | 13 | 21423176 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ATP6V1B1 STK26 ACTN4 ACTN1 PSME2 PGD TXN ATP8A1 PKM DYNC1H1 FLNA FLNB COL6A3 FAT4 NPEPPS MXRA8 VPS36 PPIB CRYZ CD9 ATP6AP2 CNDP2 PATJ ENO1 CDH13 ALDH7A1 | 6.79e-07 | 1070 | 280 | 26 | 23533145 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACA IMPDH2 GART PSME2 TXN PKM PRPF19 NIPBL HSPA9 FLNA PSAT1 EP400 ATG2B ANKRD26 PHF6 SHMT2 ECH1 SYAP1 AKAP12 RAB18 CEP44 RAI14 ENO1 HERC4 | 7.03e-07 | 934 | 280 | 24 | 33916271 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MPDZ CLPX PGD NDUFS1 BAP1 FARSA NAE1 HERC2 USP1 FLNA FLNB FLNC NSF NPEPPS WRN SHMT2 CERT1 PPIB LGALS7 YARS2 FANCI ATP6AP2 KDM1B ZRANB1 NACA4P | 7.37e-07 | 1005 | 280 | 25 | 19615732 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ACACA IMPDH2 HERC2 IQGAP3 DOCK1 FLNA FLNB CDC42BPA WRN TIAM1 AKAP13 | 8.45e-07 | 202 | 280 | 11 | 33005030 |
| Pubmed | 8.54e-07 | 64 | 280 | 7 | 22261194 | ||
| Pubmed | 9.77e-07 | 94 | 280 | 8 | 35122331 | ||
| Pubmed | PDE2A MPDZ NRXN1 TLN2 KIF5C DYNC1H1 CAMK2A SYNE1 DLGAP4 PPIB SHANK3 GDA | 1.07e-06 | 251 | 280 | 12 | 27507650 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 1.41e-06 | 171 | 280 | 10 | 20201926 | |
| Pubmed | A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum. | 1.41e-06 | 44 | 280 | 6 | 32492419 | |
| Pubmed | MYL4 IMPDH2 ACTN1 TXN PRPF19 HSPA9 FLNB FLNC MXRA8 TDRD1 PPIB ENO1 | 1.48e-06 | 259 | 280 | 12 | 31162944 | |
| Pubmed | 1.56e-06 | 173 | 280 | 10 | 23979707 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | USP34 MAGEB1 ACACA NCKAP5 NDUFS1 BPTF GPC4 CHD6 FLNA COL6A3 COL12A1 FANCI CNDP2 HERC4 | 1.75e-06 | 363 | 280 | 14 | 14691545 |
| Pubmed | IMPDH2 MRPL44 RAB1C CLPX BAP1 MSI2 BPTF BRD8 GLI2 PRPF19 CHD6 HERC2 NIPBL DYNC1H1 MOV10 CDC42BPA TCF20 EP400 CALU PHF6 ECH1 ATXN1L MRPL15 DGKK RCOR3 CTBP1 RAI14 TRAPPC3 KDM1B SPEN | 1.88e-06 | 1429 | 280 | 30 | 35140242 | |
| Pubmed | 1.93e-06 | 12 | 280 | 4 | 16018997 | ||
| Pubmed | 1.93e-06 | 12 | 280 | 4 | 16301330 | ||
| Pubmed | 2.05e-06 | 4 | 280 | 3 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 2.05e-06 | 4 | 280 | 3 | 22802962 | |
| Pubmed | USP34 BCL2L14 HK1 IMPDH2 PSME2 CLPX NDUFS1 MSI2 FARSA PRPF19 TRMT61B DYNC1H1 MOV10 FLNA FLNB PSAT1 NSF ANP32B CALU NPEPPS PON2 SHMT2 RAB18 CD9 MRPL15 FANCI CEP44 CTBP1 TRAPPC3 ENO1 | 2.19e-06 | 1440 | 280 | 30 | 30833792 | |
| Pubmed | HK1 ACACA IMPDH2 GART ACTN4 ACTN1 TXN FARSA PRPF19 HSPA9 DYNC1H1 FLNA FLNB FLNC NSF ATP6V0A2 | 2.38e-06 | 484 | 280 | 16 | 31995728 | |
| Pubmed | USP34 HECW1 DSCAML1 HEPH BAP1 NRXN1 SIK2 TLN2 CHD6 SYNE1 PSD3 | 2.42e-06 | 225 | 280 | 11 | 12168954 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 2.47e-06 | 182 | 280 | 10 | 30711629 | |
| Pubmed | HK1 IMPDH2 ACTN4 PGD NDUFS1 GPC4 PKM PRPF19 KIF5C HSPA9 DYNC1H1 MOV10 FLNA FLNB CALU SYNE1 SHMT2 PPIB RAB18 CNDP2 ENO1 | 2.72e-06 | 803 | 280 | 21 | 36517590 | |
| Pubmed | Quantitative study of the interactome of PKCζ involved in the EGF-induced tumor cell chemotaxis. | 2.72e-06 | 184 | 280 | 10 | 23402259 | |
| Pubmed | 2.77e-06 | 76 | 280 | 7 | 27542412 | ||
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 2.78e-06 | 13 | 280 | 4 | 11015572 | |
| Pubmed | USP34 GALNT1 TRIM26 CYP17A1 GOLM1 ACTN4 COLEC11 BRD8 GPC4 DSE KLHL6 FLNA TICRR FLNB SHMT2 ATXN1L AKAP12 SLFN12L CSNK1E RCOR3 KDM1B PATJ NFAT5 HERC4 ATP6V0A2 | 2.83e-06 | 1084 | 280 | 25 | 11544199 | |
| Pubmed | FAT2 PRPF19 KDR DNAH5 HSPA9 FLNA FLNB CDC42BPA SYNE1 FAT3 RAI14 | 3.53e-06 | 234 | 280 | 11 | 36243803 | |
| Pubmed | USP34 IMPDH2 TRIM26 MSI2 BRD8 GPC4 CHD6 IQGAP3 EP400 ANP32B MRPL15 SPEN | 3.56e-06 | 282 | 280 | 12 | 23667531 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | IMPDH2 HECW1 ACTN1 PKM KIF5A MPP1 FLNA FLNB VWF CAMK2A DLGAP4 APP ECH1 SHANK3 SHARPIN CTBP1 ENO1 | 3.59e-06 | 560 | 280 | 17 | 21653829 |
| Pubmed | HK1 IMPDH2 ACTN4 ACTN1 FARSA DYNC1H1 FLNA FLNB FLNC NPEPPS EFHD1 RAI14 PATJ | 3.72e-06 | 334 | 280 | 13 | 30425250 | |
| Pubmed | ACACA IMPDH2 GART ACTN4 ACTN1 PSME2 PKM MOV10 FLNB PSAT1 CALU SHMT2 PPIB AKAP12 CLIP4 AKAP9 | 3.88e-06 | 503 | 280 | 16 | 36217030 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | IMPDH2 ACTN1 TXN MYO3B GPC4 PKM HSPA9 DYNC1H1 FLNB NPEPPS RAI14 ENO1 | 4.42e-06 | 288 | 280 | 12 | 31501420 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | USP34 IMPDH2 TRIM26 PBK MPDZ PSME2 NDUFS1 FARSA PKM NME7 HSPA9 DYNC1H1 ANP32B CALU EFHD1 FANCI PATJ | 4.65e-06 | 571 | 280 | 17 | 37167062 |
| Pubmed | Multiple members of a third subfamily of P-type ATPases identified by genomic sequences and ESTs. | 5.10e-06 | 5 | 280 | 3 | 9548971 | |
| Pubmed | 5.10e-06 | 5 | 280 | 3 | 12006559 | ||
| Pubmed | 5.10e-06 | 5 | 280 | 3 | 19366992 | ||
| Pubmed | 5.10e-06 | 5 | 280 | 3 | 17360453 | ||
| Pubmed | 5.23e-06 | 15 | 280 | 4 | 18303054 | ||
| Pubmed | HK1 ACTN4 ACTN1 NDUFS1 PKM SLC17A7 HSPA9 DYNC1H1 NSF CAMK2A NPEPPS DLGAP4 GDA ENO1 | 5.83e-06 | 403 | 280 | 14 | 30562941 | |
| Interaction | FKBP1A interactions | BAP1 MSI2 TXN CALU APP PPIB PPP3R1 CTBP1 ENO1 ZRANB1 ALDH7A1 | 4.90e-07 | 113 | 279 | 11 | int:FKBP1A |
| Interaction | PSMD14 interactions | BCL2L14 IMPDH2 PSME2 BAP1 TXN GUF1 FARSA TGFBRAP1 PKM CHD6 HERC2 DNAH5 HSPA9 FLNA FLNB APP SHANK3 CD9 IKBKE ARHGAP18 PATJ ENO1 ZRANB1 | 1.34e-06 | 527 | 279 | 23 | int:PSMD14 |
| Interaction | AGR2 interactions | HK1 ACACA IMPDH2 GART ACTN4 ACTN1 PGD NSDHL TXN ADK GUF1 PKM PRPF19 IQGAP3 DYNC1H1 FLNA FLNB FLNC ANP32B NPEPPS SYNE1 SHMT2 APP ECH1 PPIB RAB18 AKAP9 CNDP2 AKAP13 ARHGAP18 ENO1 ZRANB1 | 2.30e-06 | 934 | 279 | 32 | int:AGR2 |
| Interaction | BIRC3 interactions | HK1 IMPDH2 MRPL44 GART ACTN4 HMGCL CLPX PGD NDUFS1 NSDHL TXN FARSA PKM PRPF19 TLN2 DNAH5 HSPA9 DYNC1H1 FLNA FLNB PSAT1 NSF ANP32B CALU NPEPPS SYNE1 CHAF1A PHF6 SHMT2 PPIB SYAP1 YARS2 GBA3 IKBKE CSNK1E FANCI RCL1 UBA6 SPEN ENO1 | 3.20e-06 | 1334 | 279 | 40 | int:BIRC3 |
| Interaction | FILIP1 interactions | 3.67e-06 | 31 | 279 | 6 | int:FILIP1 | |
| Interaction | KCTD13 interactions | PDE2A HK1 STK26 ACTN4 ACTN1 ITGA2 NDUFS1 TXN NDST3 FARSA ATP8A1 PTPRZ1 PKM SLC17A7 PRPF19 TLN2 DCLK2 KIF5C DNAH6 HSDL1 HSPA9 DYNC1H1 MAPK8IP1 FLNA FLNB FLNC VWF NSF CAMK2A NPEPPS SYNE1 DLGAP4 PSD3 PPIB SHANK3 GDA ITSN2 CTBP1 RAI14 TRAPPC3 ALDH7A1 | 3.82e-06 | 1394 | 279 | 41 | int:KCTD13 |
| Interaction | BAP1 interactions | HK1 ACACA IMPDH2 STK26 GART MPDZ ACTN4 ACTN1 PGD BAP1 MSI2 TXN NAE1 PKM PRPF19 IQGAP3 HSPA9 DYNC1H1 MOV10 FLNA FLNB FLNC PSAT1 NSF ANP32B CALU CAMK2A NPEPPS SHMT2 PPIB SYAP1 AKAP12 FANCI RAI14 TRAPPC3 KDM1B PATJ ENO1 ALDH7A1 | 5.49e-06 | 1314 | 279 | 39 | int:BAP1 |
| Interaction | PTEN interactions | ACACA CENPL PBK ITGA2 NDUFS1 SBSN BAP1 PTK7 TXN QRFPR FARSA GPC4 PKM PRPF19 USP1 OSGIN1 MPP1 FLNA FLNB CDC42BPA PCDHGA10 ANP32B PSD3 SHMT2 ECH1 AKAP12 CRYZ SHARPIN AKAP13 CTBP1 EPHB1 | 5.71e-06 | 929 | 279 | 31 | int:PTEN |
| Interaction | FGD5 interactions | IMPDH2 ACTN4 ACTN1 PKM HSPA9 DYNC1H1 FLNA FLNB FLNC PSAT1 ECH1 RAI14 ENO1 | 6.67e-06 | 207 | 279 | 13 | int:FGD5 |
| Interaction | MYOT interactions | 8.33e-06 | 21 | 279 | 5 | int:MYOT | |
| Interaction | GRIN1 interactions | ACTN4 DOCK1 NSF CAMK2A DLGAP4 APP SLC1A1 SHANK3 AKAP9 TIAM1 CTBP1 | 1.03e-05 | 154 | 279 | 11 | int:GRIN1 |
| Interaction | MBD1 interactions | 1.12e-05 | 77 | 279 | 8 | int:MBD1 | |
| Interaction | KCNA3 interactions | IMPDH2 GART MPDZ CDC7 FARSA PKM TLN2 DNAH5 IQGAP3 HSPA9 DYNC1H1 DOCK1 FLNB CDC42BPA NSF ATG2B PSD3 ANKRD26 PPIB SYAP1 SLC1A1 AKAP12 TBC1D8 FANCI UBA6 RAI14 PATJ SPEN ENO1 | 1.22e-05 | 871 | 279 | 29 | int:KCNA3 |
| Interaction | HSPB7 interactions | 1.68e-05 | 24 | 279 | 5 | int:HSPB7 | |
| Interaction | ACAA2 interactions | BCL2L14 IMPDH2 C9orf78 PGD PKM TRMT61B NPEPPS APP ECH1 YARS2 ENO1 ZRANB1 | 1.85e-05 | 195 | 279 | 12 | int:ACAA2 |
| Interaction | KIF3B interactions | 1.87e-05 | 60 | 279 | 7 | int:KIF3B | |
| Interaction | ALDH4A1 interactions | 1.94e-05 | 108 | 279 | 9 | int:ALDH4A1 | |
| Interaction | SAR1B interactions | ACACA GART ACTN4 ACTN1 NAE1 PKM FLNA PSAT1 ANP32B CALU NPEPPS PON2 UBA6 CTBP1 ZRANB1 ATP6V0A2 | 2.21e-05 | 339 | 279 | 16 | int:SAR1B |
| Interaction | CALM3 interactions | ACTN4 KDR IQGAP3 MOV10 FLNA FLNB APPBP2 CAMK2A POLB GRM7 CSF1R PPP3R1 AKAP9 EFHD1 RAI14 ZRANB1 | 2.55e-05 | 343 | 279 | 16 | int:CALM3 |
| Interaction | ALDOC interactions | 2.60e-05 | 140 | 279 | 10 | int:ALDOC | |
| Interaction | PDLIM5 interactions | DCDC1 IMPDH2 GART ACTN1 BAP1 GLI2 PKM DYNC1H1 DOCK1 BNIP5 FLNC CALU AKAP13 ZRANB1 | 2.93e-05 | 273 | 279 | 14 | int:PDLIM5 |
| Interaction | GAPDH interactions | RIDA TIGD7 GART ACTN4 MYCBPAP BAP1 TXN PKM TLN2 HERC2 NIPBL HSPA9 FLNA REV3L APP PPIB SHANK3 AKAP12 CRYZ CNDP2 CTBP1 SNCG ENO1 ZRANB1 | 3.25e-05 | 686 | 279 | 24 | int:GAPDH |
| Interaction | CDC42 interactions | MYL4 MYLK NEK6 ACACA GART CLPX PGD NDUFS1 BAP1 NSDHL PLEKHG1 FARSA SIK2 HERC2 IQGAP3 FLNA FLNC PSAT1 FAT4 CDC42BPA NSF SYNE1 WRN PSD3 ANKRD26 PHF6 SYAP1 AKAP12 LGALS7 YARS2 TBC1D8 RAB18 TIAM1 ATP6AP2 RAI14 ZRANB1 SPATA13 | 3.57e-05 | 1323 | 279 | 37 | int:CDC42 |
| Interaction | MDH2 interactions | HK1 MYLK TRIM26 MRPL44 CLPX NDUFS1 BAP1 GUF1 PKM TRMT61B ABCD2 HSPA9 ANP32B SHMT2 ECH1 SHANK3 YARS2 AKAP9 MRPL15 ZRANB1 ALDH7A1 | 3.72e-05 | 559 | 279 | 21 | int:MDH2 |
| Interaction | SIRT7 interactions | USP34 HK1 ACACA IMPDH2 GART ACTN4 ACTN1 PSME2 NDUFS1 BPTF HERC2 NIPBL HSPA9 DYNC1H1 MOV10 FLNA FLNB FLNC TCF20 NPEPPS APP FANCI RCL1 SPEN ZRANB1 | 4.29e-05 | 744 | 279 | 25 | int:SIRT7 |
| Interaction | MCM2 interactions | ACACA IMPDH2 GART ACTN4 ACTN1 PSME2 CLPX NDUFS1 SBSN BAP1 CDC7 TXN MYO3A FARSA PKM HSPA9 DYNC1H1 FLNA FLNB FLNC EP400 CALU SYNE1 CHAF1A ATG2B APP PPIB LGALS7 GDA FANCI ENO1 ZRANB1 | 4.33e-05 | 1081 | 279 | 32 | int:MCM2 |
| Interaction | GRIN2A interactions | 4.50e-05 | 93 | 279 | 8 | int:GRIN2A | |
| Interaction | PPP1R12A interactions | MYLK C9orf78 ACTN4 BAP1 BPTF SIK2 FLNA EML4 CHAF1A SHANK3 WIF1 UBA6 RAI14 ENO1 ZRANB1 | 4.64e-05 | 322 | 279 | 15 | int:PPP1R12A |
| Interaction | SNORA6 interactions | 5.09e-05 | 6 | 279 | 3 | int:SNORA6 | |
| Interaction | COL4A3 interactions | 5.27e-05 | 30 | 279 | 5 | int:COL4A3 | |
| Interaction | PER2 interactions | 5.55e-05 | 153 | 279 | 10 | int:PER2 | |
| Interaction | SHTN1 interactions | 5.81e-05 | 124 | 279 | 9 | int:SHTN1 | |
| Interaction | WDR1 interactions | HK1 C9orf78 BAP1 MSI2 TXN FARSA MOV10 FLNA ATP6AP2 CTBP1 ENO1 ZRANB1 | 6.03e-05 | 220 | 279 | 12 | int:WDR1 |
| Interaction | CTTN interactions | MYLK STK26 GART ACTN4 ITGA2 BAP1 SIK2 HSPA9 FLNA FLNB SHMT2 SHANK3 AKAP9 CSNK1E EFHD1 RCL1 RAI14 ZRANB1 | 6.08e-05 | 450 | 279 | 18 | int:CTTN |
| Interaction | IQCB1 interactions | HK1 ACTN4 ACTN1 PGD BAP1 GPC4 PKM IQGAP3 HSPA9 FLNA FLNB FLNC CALU ECH1 PPP3R1 ZRANB1 | 6.31e-05 | 370 | 279 | 16 | int:IQCB1 |
| Interaction | ECHS1 interactions | PGD BAP1 TRMT61B HSPA9 MOV10 ECH1 PPIB YARS2 CRYZ CNDP2 CTBP1 ZRANB1 ALDH7A1 | 6.49e-05 | 257 | 279 | 13 | int:ECHS1 |
| Interaction | SHANK3 interactions | PDE2A HECW1 ACTN4 ACTN1 PKM TLN2 KIF5A KIF5C DYNC1H1 FLNA TCF20 CAMK2A SYNE1 DLGAP4 APP SHANK3 SHARPIN ENO1 SPATA13 | 6.77e-05 | 496 | 279 | 19 | int:SHANK3 |
| Interaction | INSIG1 interactions | 7.00e-05 | 127 | 279 | 9 | int:INSIG1 | |
| Interaction | SLFN11 interactions | ACACA HECW1 C9orf78 BAP1 BPTF PKM HERC2 HSPA9 MOV10 FLNA FLNB ANP32B SHMT2 TIAM1 RAI14 DHX34 | 7.63e-05 | 376 | 279 | 16 | int:SLFN11 |
| Interaction | ATIC interactions | 7.68e-05 | 159 | 279 | 10 | int:ATIC | |
| Interaction | PINK1 interactions | ACACA IMPDH2 GART ACTN4 NDUFS1 SBSN NSDHL TXN NAE1 PKM HSPA9 DYNC1H1 MOV10 FLNA FLNB FLNC PSAT1 NPEPPS PPIB LGALS7 RAB18 RAI14 ENO1 | 7.76e-05 | 679 | 279 | 23 | int:PINK1 |
| Interaction | EMC1 interactions | PDE2A HK1 IMPDH2 NDUFS1 NSDHL MBTPS2 PKM DYNC1H1 ANP32B CALU NPEPPS PON2 ATP6AP2 ENO1 ZRANB1 ALDH7A1 ATP6V0A2 | 7.96e-05 | 418 | 279 | 17 | int:EMC1 |
| Interaction | TBCA interactions | 8.70e-05 | 102 | 279 | 8 | int:TBCA | |
| Interaction | GSTO1 interactions | 9.32e-05 | 103 | 279 | 8 | int:GSTO1 | |
| Interaction | LMTK3 interactions | 9.32e-05 | 103 | 279 | 8 | int:LMTK3 | |
| Interaction | LLGL2 interactions | 1.00e-04 | 133 | 279 | 9 | int:LLGL2 | |
| Interaction | ATP6V1A interactions | ATP6V1B1 HK1 C9orf78 ACTN4 ACTN1 NDUFS1 BAP1 PON2 SHMT2 APP SHANK3 ATP6AP2 ZRANB1 | 1.07e-04 | 270 | 279 | 13 | int:ATP6V1A |
| Interaction | PITPNB interactions | 1.09e-04 | 55 | 279 | 6 | int:PITPNB | |
| Interaction | ARPC5L interactions | 1.12e-04 | 79 | 279 | 7 | int:ARPC5L | |
| Interaction | SNCB interactions | 1.13e-04 | 35 | 279 | 5 | int:SNCB | |
| Interaction | FBXW11 interactions | C9orf78 CLPX GLI2 SIK2 KDR DYNC1H1 MOV10 DOCK1 FLNA FLNC EML4 SHMT2 APP CSF1R TIAM1 CSNK1E AKAP13 ZRANB1 | 1.14e-04 | 473 | 279 | 18 | int:FBXW11 |
| Interaction | ITGA2B interactions | 1.15e-04 | 167 | 279 | 10 | int:ITGA2B | |
| Interaction | FDPS interactions | BCL2L14 IMPDH2 ACTN4 MBTPS2 PKM MOV10 NPEPPS SHANK3 ENO1 ZRANB1 | 1.15e-04 | 167 | 279 | 10 | int:FDPS |
| Interaction | ANK3 interactions | BAP1 PKM MAPK8IP1 FLNA FLNB FLNC PPIB SHANK3 TIAM1 ENO1 ZRANB1 | 1.19e-04 | 201 | 279 | 11 | int:ANK3 |
| Interaction | ATOH1 interactions | 1.21e-04 | 80 | 279 | 7 | int:ATOH1 | |
| Interaction | ENO1 interactions | ACACA TRIM26 C9orf78 GART MPDZ BAP1 TXN PKM PRPF19 COL14A1 DCLK2 KIF5C NENF HSPA9 DYNC1H1 FLNC FAT4 DLGAP4 PPIB SHANK3 ATP6AP2 ENO1 ZRANB1 | 1.25e-04 | 701 | 279 | 23 | int:ENO1 |
| Interaction | MAP2K4 interactions | 1.31e-04 | 81 | 279 | 7 | int:MAP2K4 | |
| Interaction | GIPC3 interactions | 1.40e-04 | 8 | 279 | 3 | int:GIPC3 | |
| Interaction | TRMT2A interactions | 1.40e-04 | 139 | 279 | 9 | int:TRMT2A | |
| Interaction | DSCAM interactions | ACTN4 ACTN1 DSCAML1 GUF1 KIF5A DYNC1H1 FLNB CAMK2A SYNE1 RUFY2 | 1.40e-04 | 171 | 279 | 10 | int:DSCAM |
| Interaction | LRRC31 interactions | ACACA IMPDH2 HERC2 IQGAP3 DOCK1 FLNA FLNB CDC42BPA WRN TIAM1 AKAP13 | 1.41e-04 | 205 | 279 | 11 | int:LRRC31 |
| Interaction | SLX4 interactions | ACACA GART ACTN4 CDC7 TXN PKM NIPBL IQGAP3 HSPA9 DYNC1H1 FLNA TCF20 EP400 WRN REV3L APP LGALS7 CSNK1E FANCI ENO1 | 1.51e-04 | 572 | 279 | 20 | int:SLX4 |
| Interaction | SORBS2 interactions | 1.57e-04 | 111 | 279 | 8 | int:SORBS2 | |
| Interaction | LRRC42 interactions | 1.79e-04 | 21 | 279 | 4 | int:LRRC42 | |
| Interaction | RHOF interactions | MPDZ ACTN4 ACTN1 ITGA2 NSDHL IQGAP3 MOV10 FAT4 CDC42BPA NSF NPEPPS PSD3 ANKRD26 SYAP1 AKAP12 YARS2 TIAM1 CSNK1E FANCI ATP6AP2 RAI14 ENO1 | 1.84e-04 | 673 | 279 | 22 | int:RHOF |
| Interaction | FMR1 interactions | PDE2A ACTN4 MSI2 KIF5A KIF5C HERC2 NIPBL DYNC1H1 MOV10 TCF20 NSF CAMK2A SHMT2 SHANK3 AKAP9 SHARPIN UBA6 ENO1 ZRANB1 | 1.85e-04 | 536 | 279 | 19 | int:FMR1 |
| Interaction | CHRNA6 interactions | 1.91e-04 | 2 | 279 | 2 | int:CHRNA6 | |
| Interaction | PTPN12 interactions | 1.93e-04 | 145 | 279 | 9 | int:PTPN12 | |
| Interaction | AIFM1 interactions | BCL2L14 HK1 ACACA IMPDH2 GART ARMCX4 CLPX NDUFS1 TXN HSPA9 FLNA FLNB FLNC SLC39A3 CHAF1A SHMT2 ECH1 AKAP12 FANCI SHARPIN ZRANB1 | 1.94e-04 | 629 | 279 | 21 | int:AIFM1 |
| Interaction | PRKCA interactions | MYLK BAP1 MOV10 FLNA FLNC POLB TEP1 GRM7 SLC1A1 SHANK3 AKAP12 AKAP9 CD9 TIAM1 AKAP13 ZRANB1 | 1.95e-04 | 408 | 279 | 16 | int:PRKCA |
| Interaction | RPUSD4 interactions | MRPL44 CLPX NDUFS1 GUF1 TRMT61B HSPA9 MOV10 CAMK2A SHMT2 YARS2 MRPL15 ZRANB1 | 2.01e-04 | 250 | 279 | 12 | int:RPUSD4 |
| Interaction | CARD16 interactions | 2.07e-04 | 9 | 279 | 3 | int:CARD16 | |
| Interaction | FXR1 interactions | IMPDH2 C9orf78 ACTN1 BAP1 MSI2 CDC7 FARSA PKM HERC2 HSPA9 FLNA FLNB VWF CAMK2A ECH1 SHANK3 AKAP9 SHARPIN UBA6 ENO1 ZRANB1 SPATA13 | 2.09e-04 | 679 | 279 | 22 | int:FXR1 |
| Interaction | DNAJA3 interactions | C9orf78 MRPL44 CLPX NDUFS1 BAP1 TXN PKM TRMT61B HSPA9 DYNC1H1 OSGIN1 SHMT2 ECH1 SHANK3 ZRANB1 | 2.16e-04 | 370 | 279 | 15 | int:DNAJA3 |
| Interaction | EED interactions | IMPA1 ACACA IMPDH2 STK26 GART ACTN4 ACTN1 NDUFS1 TXN BPTF FARSA PKM PRPF19 HERC2 NIPBL HSPA9 DYNC1H1 MOV10 DNMT3B FLNA FLNB PSAT1 SLC39A3 EP400 NSF ANP32B PPIB RAB18 ITSN2 RCL1 UBA6 CNDP2 CTBP1 RAI14 SPEN ENO1 ZRANB1 | 2.16e-04 | 1445 | 279 | 37 | int:EED |
| Interaction | TAB1 interactions | TRIM26 C9orf78 NAIP BAP1 MOV10 MAPK8IP1 CAMK2A SHMT2 LGALS7 ITSN2 SHARPIN ZRANB1 | 2.17e-04 | 252 | 279 | 12 | int:TAB1 |
| Interaction | PLOD1 interactions | HK1 GART MSI2 CDC7 NAE1 COL14A1 DCLK2 HSPA9 COL12A1 CALU DLGAP4 CNDP2 ZRANB1 | 2.31e-04 | 292 | 279 | 13 | int:PLOD1 |
| Interaction | ELP1 interactions | BCL2L14 ACACA C9orf78 MYO3B PKM DYNC1H1 FLNA CAMK2A CHAF1A ZRANB1 | 2.33e-04 | 182 | 279 | 10 | int:ELP1 |
| Interaction | KLC1 interactions | ACACA IMPDH2 PBK BAP1 KIF5A KIF5C DYNC1H1 MAPK8IP1 NPEPPS APP CEP44 ZRANB1 | 2.42e-04 | 255 | 279 | 12 | int:KLC1 |
| Interaction | TAGLN interactions | 2.54e-04 | 90 | 279 | 7 | int:TAGLN | |
| Interaction | PRDX5 interactions | 2.54e-04 | 184 | 279 | 10 | int:PRDX5 | |
| Interaction | FOXRED1 interactions | 2.55e-04 | 64 | 279 | 6 | int:FOXRED1 | |
| Interaction | ACAT2 interactions | 2.55e-04 | 64 | 279 | 6 | int:ACAT2 | |
| Interaction | ATP6V0D1 interactions | ATP6V1B1 HK1 C9orf78 SLC10A7 NDUFS1 NSF APP SHANK3 ATP6AP2 ATP6V0A2 | 2.66e-04 | 185 | 279 | 10 | int:ATP6V0D1 |
| Interaction | MCM5 interactions | ACTN1 SBSN BAP1 CDC7 PLEKHG1 NAE1 PKM HSPA9 FLNA FLNB FLNC ATG2B APP FANCI ENO1 ZRANB1 | 2.70e-04 | 420 | 279 | 16 | int:MCM5 |
| Interaction | NUDC interactions | DCDC1 PGD BAP1 MBTPS2 PRPF19 DYNC1H1 MOV10 FLNB FLNC EML4 CAMK2A SHANK3 ENO1 ZRANB1 | 2.72e-04 | 337 | 279 | 14 | int:NUDC |
| Interaction | YWHAG interactions | BCL2L14 MPDZ ACTN4 PGD BAP1 PLEKHG1 SIK2 PRPF19 KDR DCLK2 KIF5A KIF5C HSPA9 DYNC1H1 FLNA TICRR BNIP5 CDC42BPA CHAF1A PSD3 ANKRD26 APP ECH1 SHANK3 AKAP9 TIAM1 CSNK1E AKAP13 RAI14 PATJ ZRANB1 ALDH7A1 SPATA13 | 2.74e-04 | 1248 | 279 | 33 | int:YWHAG |
| Interaction | PARK7 interactions | IMPDH2 ACTN1 BAP1 TXN PKM NENF HSPA9 MAPK8IP1 EFCAB6 ANP32B APP PPIB CRYZ ENO1 ZRANB1 | 2.79e-04 | 379 | 279 | 15 | int:PARK7 |
| Interaction | PSMD10 interactions | 2.90e-04 | 187 | 279 | 10 | int:PSMD10 | |
| Interaction | DVL2 interactions | ACACA ATP9B FREM1 CDC7 FAT2 PKM PRPF19 IQGAP3 HSPA9 TCF20 SYNE1 DLGAP4 CASQ1 REV3L AKAP9 CSNK1E FANCI CEP44 ZRANB1 | 3.00e-04 | 557 | 279 | 19 | int:DVL2 |
| Interaction | GRM5 interactions | 3.07e-04 | 43 | 279 | 5 | int:GRM5 | |
| Interaction | CHMP5 interactions | 3.10e-04 | 93 | 279 | 7 | int:CHMP5 | |
| Interaction | HINT2 interactions | MRPL44 CLPX PGD NDUFS1 GUF1 TRMT61B NENF HSPA9 SHMT2 APP CRYZ MRPL15 ENO1 ZRANB1 | 3.26e-04 | 343 | 279 | 14 | int:HINT2 |
| Interaction | ISOC2 interactions | 3.28e-04 | 67 | 279 | 6 | int:ISOC2 | |
| Interaction | KNSTRN interactions | 3.32e-04 | 94 | 279 | 7 | int:KNSTRN | |
| Interaction | SPSB4 interactions | 3.36e-04 | 124 | 279 | 8 | int:SPSB4 | |
| Interaction | CDC73 interactions | HK1 ACACA ACTN4 ACTN1 PGD MYO3B PKM HSPA9 DNMT3B FLNA FLNB FLNC ANP32B ENO1 ZRANB1 | 3.39e-04 | 386 | 279 | 15 | int:CDC73 |
| Interaction | ACO2 interactions | ACTN4 HMGCL NDUFS1 ABCD2 NENF HSPA9 GPD1 SHMT2 APP ECH1 ATXN1L ENO1 ZRANB1 | 3.40e-04 | 304 | 279 | 13 | int:ACO2 |
| Interaction | KLF3 interactions | IMPDH2 BPTF CHD6 NIPBL EP400 APP ATXN1L CRYZ RCOR3 CTBP1 ZRANB1 | 3.53e-04 | 228 | 279 | 11 | int:KLF3 |
| Interaction | SOD1 interactions | ATP6V1B1 IMPDH2 HECW1 ACTN4 PSME2 BAP1 TXN ADK NENF HSPA9 ANP32B PPIB CRYZ ENO1 ZRANB1 ALDH7A1 | 3.59e-04 | 431 | 279 | 16 | int:SOD1 |
| Cytoband | 16q23.3 | 3.57e-05 | 11 | 280 | 3 | 16q23.3 | |
| GeneFamily | ATPase phospholipid transporting | 1.38e-05 | 15 | 187 | 4 | 1210 | |
| GeneFamily | Myosins, class III|Deafness associated genes | 1.06e-04 | 2 | 187 | 2 | 1099 | |
| GeneFamily | Collagens | 1.09e-04 | 46 | 187 | 5 | 490 | |
| GeneFamily | Fibronectin type III domain containing | 2.64e-04 | 160 | 187 | 8 | 555 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.02e-04 | 66 | 187 | 5 | 722 | |
| GeneFamily | Actinins | 6.30e-04 | 4 | 187 | 2 | 1112 | |
| GeneFamily | Cadherin related | 6.65e-04 | 17 | 187 | 3 | 24 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.45e-03 | 161 | 187 | 7 | 593 | |
| GeneFamily | EF-hand domain containing | 2.04e-03 | 219 | 187 | 8 | 863 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 3.26e-03 | 29 | 187 | 3 | 396 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 3.65e-03 | 9 | 187 | 2 | 1223 | |
| GeneFamily | Doublecortin superfamily | 4.53e-03 | 10 | 187 | 2 | 1369 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 4.53e-03 | 10 | 187 | 2 | 100 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | RIDA PDE2A ACTN1 TXN ADK NRXN1 PTX3 NAE1 PRPF19 KIF5C HERC2 HSPA9 DYNC1H1 MPP1 MAPK8IP1 PSAT1 VWF CAMK2A NPEPPS PSD3 PON2 APP ECH1 SLC1A1 AKAP12 MEMO1 CRYZ PPP3R1 MRPL15 ATP6AP2 ITSN2 WIF1 TENM1 SNCG | 5.34e-07 | 1248 | 279 | 34 | M17728 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | RIDA DCDC1 NEK6 MPDZ GOLM1 NCKAP5 FAT2 NRXN1 PTPRZ1 GPC4 SEL1L3 DCLK2 DNAH6 FLNC PSAT1 FAT3 MXRA8 PON2 CDH13 EPHB1 | 7.76e-06 | 600 | 279 | 20 | M39055 |
| Coexpression | GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | IMPA1 ACTN4 CDC7 TXN FARSA COL6A3 CHAF1A SHMT2 CRYZ TIAM1 ENO1 | 1.02e-05 | 199 | 279 | 11 | M8299 |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN | NEK6 IMPDH2 MRPL44 PBK LMNTD1 PSAT1 FAT4 EFCAB6 SLC39A3 LGALS7 CACNG8 | 1.02e-05 | 199 | 279 | 11 | M7443 |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_DN | BCL2L14 STK26 ACTN1 MYO3A CNGA1 EFCAB6 SYNE1 PSD3 APP CSNK1E ATP6V0A2 | 1.02e-05 | 199 | 279 | 11 | M5729 |
| Coexpression | GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN | IMPDH2 HMGCL CDC7 TXN PKM CHAF1A SHMT2 CRYZ TIAM1 FANCI ENO1 | 1.07e-05 | 200 | 279 | 11 | M8332 |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_UP | BCL2L14 MYO3A CNGA1 DSE TCAF2 SYNE1 PSD3 APP AKAP12 PPP3R1 ATP6V0A2 | 1.07e-05 | 200 | 279 | 11 | M5673 |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST | 1.18e-05 | 131 | 279 | 9 | M1687 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 1.23e-05 | 166 | 279 | 10 | M5354 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | HK1 GALNT1 MYLK ACTN1 ITGA2 PGD PTK7 TXN GLI2 DSE FLNA COL6A3 PSAT1 COL12A1 CALU MXRA8 SHMT2 AKAP12 AKAP13 RAI14 ENO1 | 1.48e-05 | 681 | 279 | 21 | M39175 |
| Coexpression | FEVR_CTNNB1_TARGETS_UP | PDE2A TRIM26 NAIP CMPK2 HEPACAM2 PGD ADK PLEKHG1 ATP8A1 PKD1 GPC4 OSGIN1 GPD1 BNIP5 HSD17B7 XDH SLC1A1 CSF1R KCNK5 DHX34 ATP6V0A2 | 1.73e-05 | 688 | 279 | 21 | M2342 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | PDE2A GALNT1 ACTN1 PLEKHG1 KDR FLNB APP SHANK3 AKAP12 CD9 CSNK1E CLEC4G RAI14 | 1.86e-05 | 295 | 279 | 13 | M39121 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | RIDA USP34 STK26 PBK ITGA2 ADK NAE1 NME7 USP1 PSAT1 APPBP2 ANKRD26 PHF6 CRYZ AKAP9 WIF1 | 1.91e-05 | 434 | 279 | 16 | M15150 |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST | 2.00e-05 | 140 | 279 | 9 | MM1211 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | MYLK IMPDH2 MATN2 COLEC11 SGCE NENF COL6A3 CALU MXRA8 APP AKAP12 ATP6AP2 ALDH7A1 | 2.22e-05 | 300 | 279 | 13 | M41708 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.48e-05 | 180 | 279 | 10 | M8239 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | RIDA USP34 STK26 PBK ITGA2 ADK NAE1 NME7 USP1 PSAT1 APPBP2 ANKRD26 PHF6 CRYZ AKAP9 WIF1 | 2.80e-05 | 448 | 279 | 16 | MM1044 |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_UP | 3.84e-05 | 152 | 279 | 9 | MM488 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_UP | 3.84e-05 | 152 | 279 | 9 | M366 | |
| Coexpression | BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS | 4.26e-05 | 60 | 279 | 6 | M40007 | |
| Coexpression | JONES_OVARY_STROMAL | 4.70e-05 | 156 | 279 | 9 | M48352 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 GALNT1 ATP8B1 BPTF PTX3 KIF5C NIPBL DOCK1 FLNB APPBP2 CDC42BPA NPEPPS WRN PSD3 REV3L APP PPP3R1 AKAP9 TIAM1 ITSN2 AKAP13 SPEN HERC4 | 5.02e-05 | 856 | 279 | 23 | M4500 |
| Coexpression | BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP | 5.32e-05 | 20 | 279 | 4 | M45002 | |
| Coexpression | BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP | 5.32e-05 | 20 | 279 | 4 | MM1336 | |
| Coexpression | JONES_OVARY_T_CELL | 5.42e-05 | 91 | 279 | 7 | M48354 | |
| Coexpression | GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP | CENPL ACTN1 CD84 SLC17A7 PARP9 KLHL6 POLR3GL CD9 ARHGAP18 SPATA13 | 5.81e-05 | 199 | 279 | 10 | M6934 |
| Coexpression | AIZARANI_LIVER_C32_MVECS_3 | 5.99e-05 | 125 | 279 | 8 | M39131 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | PDE2A TRIM26 TGFBRAP1 CHD6 DYNC1H1 CASQ1 CERT1 AKAP13 HERC4 SPATA13 | 6.06e-05 | 200 | 279 | 10 | M9463 |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP | 6.06e-05 | 200 | 279 | 10 | M8308 | |
| Coexpression | GSE27786_NKTCELL_VS_NEUTROPHIL_UP | GALNT1 ITGA2 PARP9 NENF PHF6 REV3L MRPL15 CNDP2 ARHGAP18 PATJ | 6.06e-05 | 200 | 279 | 10 | M4868 |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 6.06e-05 | 200 | 279 | 10 | M5089 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP | 6.06e-05 | 200 | 279 | 10 | M9051 | |
| Coexpression | GABRIELY_MIR21_TARGETS | USP34 MPDZ PARP9 NIPBL VPS36 REV3L CLIP4 FANCI ITSN2 RAI14 NFAT5 ZRANB1 | 6.91e-05 | 289 | 279 | 12 | M2196 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 8.74e-05 | 169 | 279 | 9 | M39230 | |
| Coexpression | NABA_COLLAGENS | 9.11e-05 | 43 | 279 | 5 | MM17060 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | RIDA HK1 MYL4 IMPA1 GALNT1 MATN2 GART CLPX PGD CDC7 TXN CD84 ADK BRD8 PTX3 PRPF19 NME7 USP1 HSPA9 DNMT3B MPP1 FLNA CDC42BPA CALU NPEPPS WRN SHMT2 ATP6AP2 RCL1 KCNK5 TRAPPC3 | 9.68e-05 | 1399 | 279 | 31 | M535 |
| Coexpression | JONES_OVARY_PERICYTE | 9.99e-05 | 172 | 279 | 9 | M48351 | |
| Coexpression | NABA_COLLAGENS | 1.02e-04 | 44 | 279 | 5 | M3005 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | RIDA PDE2A MYLK MATN2 MPDZ ACTN1 ARMCX4 APOBR MSI2 TXN PIK3C2G SGCE DNMT3B FLNB VWF APP SLC1A1 SHANK3 RAI14 PATJ | 1.02e-04 | 721 | 279 | 20 | M1999 |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN | NEK6 CD84 GPC4 PKM MPP1 VWF CSF1R CD9 ATP6AP2 RAI14 ARHGAP18 | 1.02e-04 | 256 | 279 | 11 | M41152 |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | PDE2A GALNT1 ACTN1 PLEKHG1 KDR FLNB CALU APP SHANK3 AKAP12 CLEC4G CDH13 | 1.12e-04 | 304 | 279 | 12 | M39113 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | RIDA IMPA1 GOLM1 ACTN4 PSME2 SEL1L3 PKM KDR HERC2 NENF FLNC APPBP2 CDC42BPA REV3L APP SLC1A1 MEMO1 AKAP9 MRPL15 AKAP13 RAI14 | 1.24e-04 | 790 | 279 | 21 | M12490 |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP | 1.30e-04 | 178 | 279 | 9 | M383 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KCNH7 CENPL PBK CDC7 NRXN1 PTPRZ1 SEL1L3 PKM DCLK2 KIF5C IQGAP3 MAPK8IP1 TICRR CHAF1A PHF6 REV3L SLC7A14 FANCI PNMA8A | 1.39e-04 | 680 | 279 | 19 | MM456 |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | HK1 NRXN1 SLC17A7 COL14A1 TLN2 KIF5C DSE MAPK8IP1 FLNA FLNB AKAP12 CD9 ATP6AP2 TENM1 AKAP13 | 1.40e-04 | 461 | 279 | 15 | M14127 |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | NEK6 NAIP DSCAML1 ADK GPC4 SLC17A7 TLN2 KIF5A COL6A3 FAT4 VWF TBC1D30 CALU CSF1R CD9 ATP6AP2 TENM1 RAI14 ARHGAP18 ALDH7A1 | 1.45e-04 | 740 | 279 | 20 | M41202 |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 1.51e-04 | 107 | 279 | 7 | MM947 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | RIDA DCDC1 NCKAP5 FAT2 GPC4 MED12L DNAH6 FLNC PSAT1 FAT3 PSD3 PON2 RAI14 | 1.58e-04 | 364 | 279 | 13 | M39057 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | RIDA DCDC1 MPDZ FAT2 GPC4 KIF5C DNAH6 FLNC PSAT1 CALU FAT3 MXRA8 PON2 MEMO1 CRYZ RAI14 CDH13 | 1.58e-04 | 574 | 279 | 17 | M39056 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 1.67e-04 | 184 | 279 | 9 | M9005 | |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 1.70e-04 | 109 | 279 | 7 | M2451 | |
| Coexpression | SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP | 1.82e-04 | 27 | 279 | 4 | M14614 | |
| Coexpression | TAGHAVI_NEOPLASTIC_TRANSFORMATION | 1.85e-04 | 11 | 279 | 3 | M9267 | |
| Coexpression | NABA_CORE_MATRISOME | MATN2 EMILIN3 COL6A5 PXDNL COL14A1 COL6A3 COL12A1 VWF COL20A1 VWA7 PODN | 1.91e-04 | 275 | 279 | 11 | M5884 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | MYLK NEK6 PBK NRXN1 PTPRZ1 DCLK2 DNAH6 DOCK1 PSAT1 PON2 FANCI CDH13 | 2.07e-04 | 325 | 279 | 12 | M39053 |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | IMPA1 ACACA ACTN1 CDC7 TXN USP1 FLNA FLNB CHAF1A FANCI RAI14 | 2.30e-04 | 281 | 279 | 11 | M4077 |
| Coexpression | GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN | 2.33e-04 | 152 | 279 | 8 | M432 | |
| Coexpression | GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN | 2.57e-04 | 195 | 279 | 9 | M7287 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.63e-04 | 117 | 279 | 7 | M39300 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | GALNT1 ACACA STK26 ATP9B NSDHL ADK NAE1 SEL1L3 TRMT61B USP1 NIPBL DYNC1H1 MPP1 FLNB APPBP2 EML4 NPEPPS SHMT2 KRBOX4 ECH1 PPP3R1 FANCI CNDP2 RCOR3 NFAT5 ENO1 EPHB1 | 2.66e-04 | 1215 | 279 | 27 | M41122 |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_UP | 2.77e-04 | 197 | 279 | 9 | M3354 | |
| Coexpression | ERBB2_UP.V1_DN | 2.77e-04 | 197 | 279 | 9 | M2635 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_STROMAL_CELLS | 2.78e-04 | 156 | 279 | 8 | M40151 | |
| Coexpression | GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 2.87e-04 | 198 | 279 | 9 | M3324 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 2.87e-04 | 198 | 279 | 9 | M8274 | |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 2.88e-04 | 242 | 279 | 10 | M2128 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | TXN PKM COL14A1 DYNC1H1 COL6A3 COL12A1 CALU MXRA8 AKAP12 EFHD1 ENO1 | 2.93e-04 | 289 | 279 | 11 | M41750 |
| Coexpression | JONES_OVARY_MACROPHAGE | MYLK IMPDH2 ACTN4 SGCE KDR MXRA8 SHANK3 CD9 ARHGAP18 ALDH7A1 | 2.97e-04 | 243 | 279 | 10 | M48355 |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN | 2.98e-04 | 199 | 279 | 9 | M4640 | |
| Coexpression | GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN | 2.98e-04 | 199 | 279 | 9 | M3204 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 2.98e-04 | 199 | 279 | 9 | M8381 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP | 2.98e-04 | 199 | 279 | 9 | M3915 | |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 2.98e-04 | 199 | 279 | 9 | M6003 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 2.98e-04 | 199 | 279 | 9 | MM991 | |
| Coexpression | GSE6875_WT_VS_FOXP3_KO_TREG_DN | 2.98e-04 | 199 | 279 | 9 | M6804 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 2.98e-04 | 199 | 279 | 9 | M2155 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 3.03e-04 | 158 | 279 | 8 | M372 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.03e-04 | 158 | 279 | 8 | MM17063 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 3.07e-04 | 244 | 279 | 10 | M40312 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 3.09e-04 | 200 | 279 | 9 | M9411 | |
| Coexpression | GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP | 3.09e-04 | 200 | 279 | 9 | M3382 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN | 3.09e-04 | 200 | 279 | 9 | M9315 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP | 3.09e-04 | 200 | 279 | 9 | M4570 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_DN | 3.09e-04 | 200 | 279 | 9 | M4818 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP | 3.09e-04 | 200 | 279 | 9 | M4830 | |
| Coexpression | GSE27786_LIN_NEG_VS_NEUTROPHIL_DN | C9orf78 SLC17A7 MPP1 RAG1 ATXN1L CERT1 SHARPIN NFAT5 SPATA13 | 3.09e-04 | 200 | 279 | 9 | M4795 |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_UP | 3.09e-04 | 200 | 279 | 9 | M4787 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN | 3.09e-04 | 200 | 279 | 9 | M3725 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 3.09e-04 | 200 | 279 | 9 | M7289 | |
| Coexpression | GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN | 3.09e-04 | 200 | 279 | 9 | M8656 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN | 3.09e-04 | 200 | 279 | 9 | M3969 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP | 3.09e-04 | 200 | 279 | 9 | M3976 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP | 3.09e-04 | 200 | 279 | 9 | M6094 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 3.09e-04 | 200 | 279 | 9 | M7432 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN | 3.09e-04 | 200 | 279 | 9 | M6414 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 3.09e-04 | 200 | 279 | 9 | M5276 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN | 3.09e-04 | 200 | 279 | 9 | M7989 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP | 3.09e-04 | 200 | 279 | 9 | M6615 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 3.09e-04 | 200 | 279 | 9 | M5930 | |
| Coexpression | GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP | 3.09e-04 | 200 | 279 | 9 | M5220 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ACACA MATN2 STK26 MPDZ GOLM1 ACTN1 HEPH FREM1 PTX3 GLI2 GPC4 SEL1L3 COL14A1 KDR CNGA1 DSE KLHL6 FLNA TICRR COL6A3 FLNC CALU FAT3 CHAF1A PSD3 REV3L LGALS7 ENO1 | 3.00e-06 | 827 | 272 | 28 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | MYL4 NEK6 TTC39C CYP17A1 MATN2 STK26 GOLM1 ACTN1 FREM1 SBSN GLI2 GPC4 SEL1L3 COL14A1 L3HYPDH CNGA1 NENF DSE MOV10 FLNA COL6A3 FLNC FAT3 PSD3 REV3L | 3.43e-05 | 793 | 272 | 25 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | PDE2A GOLM1 ATP8B1 ITGA2 NDST3 CFAP54 PTX3 KDR TCAF2 VWF TBC1D30 SHANK3 TBC1D8 CD9 RAI14 SNCG CDH13 | 4.12e-05 | 428 | 272 | 17 | JC_hmvEC_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#3 | GALNT1 ATP9B ACTN4 PGD BAP1 CDC7 ADK PLEKHG1 FARSA NME7 TAF11 HSPA9 DSE FLNA APPBP2 SHMT2 SHANK3 PPP3R1 TIAM1 DGKK PTCH2 HERC4 ATP6V0A2 | 4.52e-05 | 708 | 272 | 23 | Facebase_RNAseq_e8.5_Floor Plate_2500_K3 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 HECW1 DSCAML1 FREM1 CAPN8 NRXN1 PIK3C2G TLN2 KIF5A DNAH5 FAT4 COL12A1 EFCAB6 FAT3 DGKK TENM1 | 5.45e-14 | 184 | 280 | 16 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 HECW1 DSCAML1 FREM1 CAPN8 NRXN1 PIK3C2G TLN2 KIF5A DNAH5 FAT4 COL12A1 EFCAB6 FAT3 DGKK TENM1 | 5.45e-14 | 184 | 280 | 16 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 HECW1 DSCAML1 FREM1 CAPN8 NRXN1 PIK3C2G TLN2 KIF5A DNAH5 FAT4 COL12A1 EFCAB6 FAT3 DGKK TENM1 | 5.45e-14 | 184 | 280 | 16 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 REV3L AKAP12 AKAP9 | 4.99e-10 | 200 | 280 | 13 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | MYLK ITGA2 TXN GPC4 SEL1L3 PKM COL14A1 SGCE FLNA CALU APP AKAP12 | 4.10e-09 | 194 | 280 | 12 | f44394c8a6f86483063f2f5722f003a8a0a70254 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DCDC1 MPDZ MYCBPAP CFAP54 DNAH5 DNAH6 LMNTD1 ERICH3 EFCAB6 SYNE1 ANKRD26 AKAP9 | 4.87e-09 | 197 | 280 | 12 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 REV3L AKAP12 SPATA13 | 5.46e-09 | 199 | 280 | 12 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | GALNT1 MYLK BPTF GPC4 PARP9 NIPBL CDC42BPA FAT3 REV3L PPIB AKAP9 ITSN2 | 5.46e-09 | 199 | 280 | 12 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 GOLM1 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 AKAP12 | 5.77e-09 | 200 | 280 | 12 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 GOLM1 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 AKAP12 | 5.77e-09 | 200 | 280 | 12 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 MXRA8 PSD3 REV3L AKAP12 AKAP9 | 5.77e-09 | 200 | 280 | 12 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK HECW1 COL6A5 HEPH FREM1 PLEKHG1 MYO3B COL6A3 FAT4 SYNE1 TENM1 PODN | 5.77e-09 | 200 | 280 | 12 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | USP34 MPDZ NCKAP5 BPTF KDR NIPBL FLNB FAT4 COL12A1 VWF APP ARHGAP18 | 5.77e-09 | 200 | 280 | 12 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 GOLM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 PPIB AKAP12 | 5.77e-09 | 200 | 280 | 12 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | ATP8B1 ACTN1 PLEKHG1 COLEC11 FLNB VWF SLC1A1 SHANK3 AKAP12 CD9 RAI14 | 3.43e-08 | 189 | 280 | 11 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 |
| ToppCell | facs-GAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYLK MATN2 COL6A5 PTK7 NENF PSAT1 MXRA8 PON2 PPIB AKAP12 ALDH7A1 | 3.82e-08 | 191 | 280 | 11 | 1f5d1e8c313a8dc83c06d2ee45f369b0ec507fbf |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | PDE2A MSI2 PLEKHG1 KDR TCAF2 SYNE1 APP SHANK3 AKAP12 TBC1D8 CD9 | 4.48e-08 | 194 | 280 | 11 | 660535b492445063d965095a50e1e299ce04c50a |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ACACA NCKAP5 CAPN8 ADK SLC9C1 DNAH5 SYNE1 SLC1A1 WIF1 RAI14 PATJ | 4.73e-08 | 195 | 280 | 11 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 4.73e-08 | 195 | 280 | 11 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 COL14A1 KIF5A COL6A3 SYNE1 REV3L AKAP12 SPATA13 | 5.25e-08 | 197 | 280 | 11 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | MPDZ GLI2 COL14A1 COL6A3 FAT4 COL12A1 FAT3 MXRA8 PSD3 APP AKAP12 | 5.81e-08 | 199 | 280 | 11 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 GOLM1 FREM1 PTK7 PXDNL COL14A1 COL6A3 MXRA8 PSD3 AKAP12 | 5.81e-08 | 199 | 280 | 11 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 REV3L SPATA13 | 5.81e-08 | 199 | 280 | 11 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MATN2 PRPF19 FLNA EP400 MXRA8 APP AKAP12 AKAP9 CD9 ATP6AP2 AKAP13 | 5.81e-08 | 199 | 280 | 11 | 174f6013af6eafa577f84205a62927f2b367fda3 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 AKAP12 | 5.81e-08 | 199 | 280 | 11 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-08 | 199 | 280 | 11 | 9838fed26d8572ac29e7b5fd7220180f734d750a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 AKAP12 | 6.12e-08 | 200 | 280 | 11 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | MPDZ NCKAP5 ITGA2 BPTF KDR DCLK2 FLNB FAT4 VWF REV3L ARHGAP18 | 6.12e-08 | 200 | 280 | 11 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYLK MATN2 ACTN1 ADK SLC9C1 GPC4 FLNA COL6A3 SYNE1 MXRA8 WIF1 | 6.12e-08 | 200 | 280 | 11 | 87827041663013f5e7273168dc8709d69840e7ce |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.12e-08 | 200 | 280 | 11 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.12e-08 | 200 | 280 | 11 | ac5843142e0f8a5bcd2c3a784ea13b2f955a32fd | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 AKAP12 | 6.12e-08 | 200 | 280 | 11 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 AKAP12 | 6.12e-08 | 200 | 280 | 11 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 AKAP12 | 6.12e-08 | 200 | 280 | 11 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 FREM1 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PSD3 AKAP12 | 6.12e-08 | 200 | 280 | 11 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PBK HEPACAM2 CDC7 MED12L KIF5A TICRR CHAF1A SLC7A14 FANCI CLEC4G | 7.43e-08 | 160 | 280 | 10 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.24e-07 | 180 | 280 | 10 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | BCL2L14 ACACA ITGA2 CAPN8 ADK SLC9C1 ATP8A1 SEL1L3 WIF1 PATJ | 2.35e-07 | 181 | 280 | 10 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.88e-07 | 185 | 280 | 10 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.34e-07 | 188 | 280 | 10 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE2A KDR FAT4 PCDHGA10 MXRA8 SHANK3 AKAP12 TIAM1 CLEC4G CDH13 | 3.34e-07 | 188 | 280 | 10 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.34e-07 | 188 | 280 | 10 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 3.51e-07 | 189 | 280 | 10 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | NEK6 NCKAP5 DSCAML1 QRFPR SEL1L3 SLC1A1 AKAP12 GDA KCNK5 PATJ | 3.51e-07 | 189 | 280 | 10 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ITGA2 PLEKHG1 CFAP54 ATP8A1 PIK3C2G PTPRZ1 SEL1L3 KIF5C WIF1 PATJ | 3.69e-07 | 190 | 280 | 10 | 625c08a0e5227efc46daa512fd579c3938ff76c7 |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.87e-07 | 191 | 280 | 10 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.06e-07 | 192 | 280 | 10 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | PDE2A ITGA2 PLEKHG1 SEL1L3 KDR VWF SHANK3 CD9 ARHGAP18 CDH13 | 4.26e-07 | 193 | 280 | 10 | d338a7c0585b69947c37f44aa0381619493e31ea |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | NCKAP5 ATP8B1 PLEKHG1 KDR DCLK2 FLNB FAT4 VWF SHANK3 ARHGAP18 | 4.26e-07 | 193 | 280 | 10 | af5108260783e69a7d67896c5bf64f862525926d |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 4.26e-07 | 193 | 280 | 10 | f31398dad5321a7bcb27e208bd73630e9756e897 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | NCKAP5 ATP8B1 PLEKHG1 KDR DCLK2 FLNB FAT4 VWF SHANK3 ARHGAP18 | 4.26e-07 | 193 | 280 | 10 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EMILIN3 COLEC11 NRXN1 COL14A1 TLN2 KDR MXRA8 APP AKAP12 CLEC4G | 4.26e-07 | 193 | 280 | 10 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYLK COL6A5 FREM1 PXDNL GLI2 COL14A1 COL6A3 SYNE1 FAT3 MXRA8 | 4.47e-07 | 194 | 280 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | NCKAP5 ATP8B1 PLEKHG1 KDR DOCK1 FLNB FAT4 VWF SHANK3 ARHGAP18 | 4.47e-07 | 194 | 280 | 10 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HECW1 MATN2 COL6A5 FREM1 COL14A1 COL6A3 FAT4 MXRA8 AKAP12 PODN | 4.91e-07 | 196 | 280 | 10 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.91e-07 | 196 | 280 | 10 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 PTK7 PXDNL COL14A1 COL6A3 SYNE1 MXRA8 PPIB AKAP9 | 5.14e-07 | 197 | 280 | 10 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-07 | 197 | 280 | 10 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 5.14e-07 | 197 | 280 | 10 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 5.14e-07 | 197 | 280 | 10 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK COL6A5 PTK7 PXDNL COL14A1 COL6A3 MXRA8 PSD3 PPIB AKAP12 | 5.38e-07 | 198 | 280 | 10 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | MATN2 GOLM1 COL14A1 COL6A3 FLNC COL12A1 CDC42BPA MXRA8 PSD3 CD9 | 5.38e-07 | 198 | 280 | 10 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 |
| ToppCell | (5)_Dendritic_cell-(53)_Lymphoid_DC|(5)_Dendritic_cell / shred on Cell_type and subtype | BCL2L14 GOLM1 PLEKHG1 ATP8A1 GPD1 TCAF2 PSD3 TBC1D8 SNCG DHX34 | 5.38e-07 | 198 | 280 | 10 | 548da5fa86f9756c503ed77bcdde55bc4d1a2726 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 198 | 280 | 10 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.64e-07 | 199 | 280 | 10 | 30523cf08815ca214877e33a2c52197ff8318557 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.64e-07 | 199 | 280 | 10 | b2dc3d0af6ecd3ab01779aaa1f061cb0f941cae8 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | MYLK MATN2 COL6A5 COL14A1 FLNB COL6A3 FAT4 COL12A1 PSD3 AKAP12 | 5.64e-07 | 199 | 280 | 10 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|Control_saline / Treatment groups by lineage, cell group, cell type | 5.64e-07 | 199 | 280 | 10 | 86d4e5dd3bcc6bafa48fd0211dad39a2456b53be | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.64e-07 | 199 | 280 | 10 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-07 | 199 | 280 | 10 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.64e-07 | 199 | 280 | 10 | 105709b97c55826a852aed27658e3b4af1738c8a | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | MYLK COL6A5 COL14A1 SGCE FLNB COL6A3 COL12A1 MXRA8 PSD3 AKAP12 | 5.64e-07 | 199 | 280 | 10 | d9d7f36b4b5592b7855448730044c90997b55499 |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.64e-07 | 199 | 280 | 10 | 0892957a49304ce4b6daa3657d76d8365ce0dd19 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.64e-07 | 199 | 280 | 10 | b68648b4559e452656dc9e6a0974233e842f5e0d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.64e-07 | 199 | 280 | 10 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.64e-07 | 199 | 280 | 10 | 961ad44199871be8e09d31904d383edc865ba262 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-07 | 199 | 280 | 10 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.90e-07 | 200 | 280 | 10 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | BPTF DYNC1H1 VPS36 APP SYAP1 AKAP9 MRPL15 ATP6AP2 AKAP13 ARHGAP18 | 5.90e-07 | 200 | 280 | 10 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FREM1 COL14A1 COL6A3 FAT4 COL12A1 SYNE1 MXRA8 AKAP12 TENM1 PODN | 5.90e-07 | 200 | 280 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.90e-07 | 200 | 280 | 10 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FREM1 COL14A1 COL6A3 FAT4 COL12A1 SYNE1 MXRA8 AKAP12 TENM1 PODN | 5.90e-07 | 200 | 280 | 10 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 5.90e-07 | 200 | 280 | 10 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.61e-07 | 156 | 280 | 9 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-07 | 160 | 280 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-07 | 160 | 280 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 167 | 280 | 9 | f90cf0f29c14df4f211193326699e599ef955fa4 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 169 | 280 | 9 | f38b52972a6c492ce2fd520a26bb3fc8db23bf85 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 169 | 280 | 9 | 5320da1d61806b53e0bd96bbdfdb8fd69246681b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 169 | 280 | 9 | 1000eaf5158596b4898bedcc802b31db76b05a48 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 169 | 280 | 9 | 83b854fa8fd9017df8f9207d9ced260eee98e8c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 169 | 280 | 9 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.36e-06 | 170 | 280 | 9 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-06 | 170 | 280 | 9 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-06 | 171 | 280 | 9 | d6ae456e88ec49a8609a5e5e3af9f51921e66744 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-06 | 171 | 280 | 9 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-06 | 173 | 280 | 9 | b9dc42d629d13e63aada5ae49ba0cbb0952c5fe9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-06 | 175 | 280 | 9 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 175 | 280 | 9 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 177 | 280 | 9 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| Computational | Genes in the cancer module 286 | 3.68e-05 | 37 | 186 | 6 | MODULE_286 | |
| Drug | O TG | 3.17e-07 | 13 | 279 | 5 | CID000449419 | |
| Drug | NSC521040 | 3.52e-07 | 123 | 279 | 11 | CID000001041 | |
| Drug | AC1L8RPE | 3.21e-06 | 52 | 279 | 7 | CID000407007 | |
| Drug | 2,4,4'-trichlorobiphenyl | BCL2L14 DCDC1 CYP17A1 PBK CMPK2 DSCAML1 QRFPR FARSA FAT2 BRD8 GLI2 TGFBRAP1 TLN2 KDR KIF5A IQGAP3 DNMT3B RAG1 FLNA TICRR COL6A3 COL12A1 CDC42BPA EP400 NSF CAMK2A FAT3 CHAF1A PSD3 PHF6 APP RUFY2 AKAP9 FANCI PTCH2 RCOR3 CDH7 SPATA13 | 4.24e-06 | 1411 | 279 | 38 | ctd:C081766 |
| Drug | adenine | RIDA PDE2A HK1 IMPA1 ACACA IMPDH2 GART ADK PKM NME7 DNMT3B POLB SHMT2 XDH REV3L APP YARS2 GDA CTBP1 ALDH7A1 | 5.50e-06 | 510 | 279 | 20 | CID000000190 |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | MYL4 ATP9B ACTN1 NSDHL GPC4 SEL1L3 FLNA FAT4 PSD3 AKAP9 TIAM1 ENO1 | 5.84e-06 | 196 | 279 | 12 | 6585_DN |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | MYL4 ATP8B1 ITGA2 OSGIN1 DOCK1 CDC42BPA PCDHGA10 CSF1R PPP3R1 ASB1 SNCG ALDH7A1 | 6.48e-06 | 198 | 279 | 12 | 5444_DN |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | BCL2L14 DCDC1 CYP17A1 PBK CMPK2 DSCAML1 QRFPR FARSA FAT2 BRD8 GLI2 TGFBRAP1 TLN2 KDR KIF5A IQGAP3 DNMT3B RAG1 FLNA TICRR COL6A3 COL12A1 CDC42BPA EP400 NSF CAMK2A FAT3 CHAF1A PSD3 PHF6 APP RUFY2 AKAP9 FANCI PTCH2 RCOR3 CDH7 SPATA13 | 6.88e-06 | 1441 | 279 | 38 | ctd:C009828 |
| Drug | polyribosylribitol phosphate | 1.00e-05 | 112 | 279 | 9 | CID000002219 | |
| Drug | AC1Q6S1V | 1.18e-05 | 63 | 279 | 7 | CID000000620 | |
| Drug | hydroxyl radicals | ATP6V1B1 PDE2A HK1 IMPA1 IMPDH2 CYP17A1 GART ATP9B ATP8B1 ITGA2 NDUFS1 PTK7 NSDHL TXN ATP8A1 PTPRZ1 PXDNL PKM SLC17A7 USP1 MAPK8IP1 ATP8B3 PLCZ1 COL6A3 HSD17B7 VWF NSF PON2 SHMT2 XDH GBA3 GDA ENO1 ALDH7A1 ATP6V0A2 | 2.04e-05 | 1341 | 279 | 35 | CID000000961 |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; HL60; HT_HG-U133A | RIDA USP34 MYL4 BAP1 MBTPS2 NIPBL FLNB CALU CRYZ PPP3R1 ASB1 | 2.41e-05 | 190 | 279 | 11 | 1286_UP |
| Drug | AC1L2E5V | 2.49e-05 | 29 | 279 | 5 | CID000019458 | |
| Drug | arabinosyladenine | PDE2A HK1 IMPA1 MYLK IMPDH2 GART PGD ADK FARSA PIK3C2G PKD1 PKM TRMT61B DSE GPD1 VWF CALU POLB XDH GRM7 GRK1 YARS2 GDA ALDH7A1 | 2.53e-05 | 762 | 279 | 24 | CID000000191 |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | USP34 KIF5C RAB26 CDC42BPA PSD3 TEP1 AKAP13 SPEN NFAT5 HERC4 CDH7 | 2.53e-05 | 191 | 279 | 11 | 4283_DN |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A | MRPL44 ATP8A1 GLI2 GPC4 COL14A1 SGCE OSGIN1 TDRD1 RAI14 SNCG ALDH7A1 | 3.21e-05 | 196 | 279 | 11 | 6928_UP |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | USP34 MBTPS2 NIPBL PSD3 AKAP12 BBS7 EFHD1 SHARPIN ASB1 PATJ HERC4 | 3.36e-05 | 197 | 279 | 11 | 1015_DN |
| Drug | tris(p-nitrophenyl) phosphate | 3.54e-05 | 6 | 279 | 3 | CID000077473 | |
| Drug | 2,6-di-tert-butylpyridine | 3.54e-05 | 6 | 279 | 3 | CID000068510 | |
| Drug | 2-methyleneglutarate | 3.58e-05 | 16 | 279 | 4 | CID000095155 | |
| Drug | Debrisoquin sulfate [581-88-4]; Down 200; 9uM; PC3; HT_HG-U133A | MYL4 COL14A1 CDC42BPA DLGAP4 XDH APP CSF1R CSNK1E AKAP13 PATJ CDH7 | 3.86e-05 | 200 | 279 | 11 | 6688_DN |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 8.01e-07 | 3 | 275 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 8.01e-07 | 3 | 275 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 4.11e-06 | 206 | 275 | 11 | C0152013 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.68e-05 | 156 | 275 | 9 | C0007131 | |
| Disease | Intellectual Disability | HK1 HMGCL ADK BPTF NRXN1 MED12L KIF5A DYNC1H1 TCF20 NSF CAMK2A SYNE1 CERT1 SHANK3 BBS7 | 2.26e-05 | 447 | 275 | 15 | C3714756 |
| Disease | lifestyle measurement, depressive symptom measurement | 5.92e-05 | 105 | 275 | 7 | EFO_0007006, EFO_0010724 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.81e-05 | 145 | 275 | 8 | DOID:1289 (implicated_via_orthology) | |
| Disease | von Willebrand's disease 2 (is_implicated_in) | 8.65e-05 | 2 | 275 | 2 | DOID:0060574 (is_implicated_in) | |
| Disease | Phelan-McDermid syndrome (implicated_via_orthology) | 8.65e-05 | 2 | 275 | 2 | DOID:0080354 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.47e-05 | 152 | 275 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Prescription Drug Abuse | 1.05e-04 | 115 | 275 | 7 | C4316881 | |
| Disease | Substance-Related Disorders | 1.05e-04 | 115 | 275 | 7 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.05e-04 | 115 | 275 | 7 | C0029231 | |
| Disease | Drug habituation | 1.05e-04 | 115 | 275 | 7 | C0013170 | |
| Disease | Drug abuse | 1.05e-04 | 115 | 275 | 7 | C0013146 | |
| Disease | Drug Use Disorders | 1.05e-04 | 115 | 275 | 7 | C0013222 | |
| Disease | Drug Dependence | 1.05e-04 | 115 | 275 | 7 | C1510472 | |
| Disease | Substance Dependence | 1.05e-04 | 115 | 275 | 7 | C0038580 | |
| Disease | Substance Use Disorders | 1.05e-04 | 115 | 275 | 7 | C0038586 | |
| Disease | Substance abuse problem | 1.11e-04 | 116 | 275 | 7 | C0740858 | |
| Disease | retinal drusen | 1.12e-04 | 51 | 275 | 5 | EFO_1001155 | |
| Disease | Carcinomatosis | 1.54e-04 | 163 | 275 | 8 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.54e-04 | 163 | 275 | 8 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.54e-04 | 163 | 275 | 8 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.54e-04 | 163 | 275 | 8 | C0205696 | |
| Disease | Carcinoma | 1.60e-04 | 164 | 275 | 8 | C0007097 | |
| Disease | Malignant neoplasm of breast | PDE2A CYP17A1 ATP8B1 HEPACAM2 BAP1 TXN KDR HERC2 NIPBL DNMT3B FLNA FLNB VWF SYNE1 XDH AKAP12 CSF1R AKAP9 ITSN2 TENM1 SNCG SPEN ENO1 | 2.02e-04 | 1074 | 275 | 23 | C0006142 |
| Disease | EMILIN-3 measurement | 2.58e-04 | 3 | 275 | 2 | EFO_0801563 | |
| Disease | Early onset schizophrenia | 2.58e-04 | 3 | 275 | 2 | C1656427 | |
| Disease | Malformations of Cortical Development | 2.70e-04 | 14 | 275 | 3 | C1955869 | |
| Disease | Cortical Dysplasia | 2.70e-04 | 14 | 275 | 3 | C0431380 | |
| Disease | urate measurement | USP34 ATP6V1B1 DCDC1 DCST1 TXN NRXN1 TGFBRAP1 MYO3B ATP8B3 PSD3 SHMT2 XDH APP TBC1D8 GBA3 KCNK5 AKAP13 RAI14 NFAT5 HERC4 | 3.07e-04 | 895 | 275 | 20 | EFO_0004531 |
| Disease | Liver carcinoma | ACACA CYP17A1 PBK PGD MBTPS2 PKM IQGAP3 HSPA9 TICRR GBA3 FANCI CLEC4G ENO1 CDH13 | 3.22e-04 | 507 | 275 | 14 | C2239176 |
| Disease | Colorectal Carcinoma | ACACA DSCAML1 NDST3 KDR ABCD2 FLNC SYNE1 WRN AKAP12 TNNI3K AKAP9 CD9 TIAM1 WIF1 TENM1 CTBP1 CDH7 | 3.52e-04 | 702 | 275 | 17 | C0009402 |
| Disease | Mammary Carcinoma, Animal | 3.86e-04 | 142 | 275 | 7 | C1257925 | |
| Disease | Animal Mammary Neoplasms | 3.86e-04 | 142 | 275 | 7 | C0024667 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 4.10e-04 | 16 | 275 | 3 | EFO_0004569, MONDO_0009354 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 5.13e-04 | 4 | 275 | 2 | C0410179 | |
| Disease | retinoblastoma (is_marker_for) | 5.13e-04 | 4 | 275 | 2 | DOID:768 (is_marker_for) | |
| Disease | age-related macular degeneration, cataract, glaucoma | 5.13e-04 | 4 | 275 | 2 | EFO_0001365, MONDO_0005041, MONDO_0005129 | |
| Disease | Bethlem myopathy (is_implicated_in) | 5.13e-04 | 4 | 275 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Premature aging syndrome | 5.13e-04 | 4 | 275 | 2 | C0231341 | |
| Disease | Juvenile Spinal Muscular Atrophy | 5.13e-04 | 4 | 275 | 2 | C0152109 | |
| Disease | Ullrich congenital muscular dystrophy | 5.13e-04 | 4 | 275 | 2 | cv:C4551860 | |
| Disease | Muscular Atrophy, Spinal, Type II | 5.13e-04 | 4 | 275 | 2 | C0393538 | |
| Disease | Bethlem myopathy | 5.13e-04 | 4 | 275 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 5.13e-04 | 4 | 275 | 2 | C1834674 | |
| Disease | Muscular atrophy, spinal, infantile chronic form | 5.13e-04 | 4 | 275 | 2 | C2931358 | |
| Disease | von Willebrand's disease 1 (is_implicated_in) | 5.13e-04 | 4 | 275 | 2 | DOID:0060573 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 5.13e-04 | 4 | 275 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | HMN (Hereditary Motor Neuropathy) Proximal Type I | 5.13e-04 | 4 | 275 | 2 | C0043116 | |
| Disease | Breast Carcinoma | PDE2A CYP17A1 BAP1 TXN KDR HERC2 DNMT3B FLNA SYNE1 AKAP12 CSF1R ITSN2 SNCG ENO1 | 5.79e-04 | 538 | 275 | 14 | C0678222 |
| Disease | Schizophrenia | 5.89e-04 | 18 | 275 | 3 | cv:C0036341 | |
| Disease | Bipolar Disorder | IMPA1 NDST3 NRXN1 SLC17A7 CHRNA6 SLC39A3 CAMK2A SYNE1 APP GRM7 SLC1A1 CSNK1E CDH7 | 5.91e-04 | 477 | 275 | 13 | C0005586 |
| Disease | mean platelet volume | MYL4 ACTN4 ACTN1 ITGA2 APOBR MSI2 QRFPR BRD8 TAF11 DSE VWF PCDHGA10 PCDHGA5 NPEPPS PSD3 VWA7 CERT1 SHANK3 CD9 ARHGAP18 PCDHGA8 | 6.36e-04 | 1020 | 275 | 21 | EFO_0004584 |
| Disease | Mammary Neoplasms, Experimental | 6.52e-04 | 155 | 275 | 7 | C0024668 | |
| Disease | Schizophrenia | HK1 NDUFS1 ADK NDST3 NRXN1 PTPRZ1 SLC17A7 KDR HSPA9 DNMT3B PSAT1 PSD3 GRM7 SLC1A1 SHANK3 CACNG8 PPP3R1 CSNK1E ARHGAP18 | 6.82e-04 | 883 | 275 | 19 | C0036341 |
| Disease | diet measurement, HOMA-B | 6.95e-04 | 19 | 275 | 3 | EFO_0004469, EFO_0008111 | |
| Disease | Osteochondrodysplasias | 6.95e-04 | 19 | 275 | 3 | C0029422 | |
| Disease | Esophageal Neoplasms | 8.22e-04 | 78 | 275 | 5 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 8.22e-04 | 78 | 275 | 5 | C0546837 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 8.50e-04 | 5 | 275 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Basal Cell Nevus Syndrome | 8.50e-04 | 5 | 275 | 2 | C0004779 | |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 8.50e-04 | 5 | 275 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | Macrothrombocytopenia | 8.50e-04 | 5 | 275 | 2 | C2751260 | |
| Disease | cognitive function measurement | USP34 KCNH7 ATP8B1 MSI2 CAPN8 PLEKHG1 MYO3A NRXN1 MED12L DNAH5 LMNTD1 TCF20 NSF CALU PCDHGA5 WRN PSD3 APP STK31 GRM7 SHANK3 TNNI3K PPP3R1 ITSN2 CDH7 CDH13 | 9.81e-04 | 1434 | 275 | 26 | EFO_0008354 |
| Disease | Autism Spectrum Disorders | 1.21e-03 | 85 | 275 | 5 | C1510586 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 1.24e-03 | 23 | 275 | 3 | EFO_0006919, GO_1903493 | |
| Disease | insulin-like growth factor-binding protein 7 measurement | 1.27e-03 | 6 | 275 | 2 | EFO_0008161 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.27e-03 | 6 | 275 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Astigmatism | 1.36e-03 | 129 | 275 | 6 | HP_0000483 | |
| Disease | Mammary Carcinoma, Human | PDE2A CYP17A1 BAP1 TXN KDR DNMT3B FLNA SYNE1 AKAP12 CSF1R ITSN2 SNCG ENO1 | 1.41e-03 | 525 | 275 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | PDE2A CYP17A1 BAP1 TXN KDR DNMT3B FLNA SYNE1 AKAP12 CSF1R ITSN2 SNCG ENO1 | 1.41e-03 | 525 | 275 | 13 | C1257931 |
| Disease | Mammary Neoplasms | PDE2A CYP17A1 BAP1 TXN KDR DNMT3B FLNA SYNE1 AKAP12 CSF1R ITSN2 SNCG ENO1 | 1.46e-03 | 527 | 275 | 13 | C1458155 |
| Disease | response to peginterferon alfa-2a | 1.58e-03 | 25 | 275 | 3 | EFO_0010103 | |
| Disease | mental development measurement | 1.58e-03 | 25 | 275 | 3 | EFO_0008230 | |
| Disease | retinal detachment | 1.76e-03 | 7 | 275 | 2 | EFO_0005773 | |
| Disease | ergothioneine measurement | 1.78e-03 | 26 | 275 | 3 | EFO_0021163 | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.82e-03 | 293 | 275 | 9 | C1708349 | |
| Disease | uric acid measurement | USP34 DCDC1 TXN SIK2 FAT4 CDC42BPA FAT3 GBA3 KCNK5 AKAP13 RAI14 NFAT5 HERC4 PLAAT5 | 1.90e-03 | 610 | 275 | 14 | EFO_0004761 |
| Disease | Stomach Neoplasms | 1.99e-03 | 297 | 275 | 9 | C0038356 | |
| Disease | Major Depressive Disorder | 2.11e-03 | 243 | 275 | 8 | C1269683 | |
| Disease | Malignant neoplasm of stomach | 2.13e-03 | 300 | 275 | 9 | C0024623 | |
| Disease | Pigmented Basal Cell Carcinoma | 2.21e-03 | 28 | 275 | 3 | C1368275 | |
| Disease | memory impairment | 2.34e-03 | 8 | 275 | 2 | EFO_0001072 | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 2.34e-03 | 8 | 275 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 2.34e-03 | 8 | 275 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | Carcinoma, Basal Cell | 2.45e-03 | 29 | 275 | 3 | C4721806 | |
| Disease | Mental Depression | 2.77e-03 | 254 | 275 | 8 | C0011570 | |
| Disease | Seizures, Focal | 2.94e-03 | 104 | 275 | 5 | C0751495 | |
| Disease | platelet measurement | 2.95e-03 | 315 | 275 | 9 | EFO_0005036 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 2.97e-03 | 31 | 275 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | progressive supranuclear palsy | 2.97e-03 | 31 | 275 | 3 | MONDO_0019037 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.97e-03 | 257 | 275 | 8 | DOID:10652 (is_marker_for) | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 2.98e-03 | 9 | 275 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | uveal melanoma (is_marker_for) | 2.98e-03 | 9 | 275 | 2 | DOID:6039 (is_marker_for) | |
| Disease | intraocular pressure measurement | COLEC11 HERC2 TRMT61B COL6A3 NSF PCDHGA5 MXRA8 TBC1D8 PTCH2 KCNK5 AKAP13 TRAPPC3 | 3.17e-03 | 509 | 275 | 12 | EFO_0004695 |
| Disease | heart conduction disease (implicated_via_orthology) | 3.25e-03 | 32 | 275 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | frontotemporal dementia | 3.25e-03 | 32 | 275 | 3 | MONDO_0017276 | |
| Disease | severe acute respiratory syndrome, COVID-19 | NRXN1 PIK3C2G GLI2 MYO3B ATP8B3 COL6A3 WRN PSD3 GRM7 PATJ CDH13 | 3.37e-03 | 447 | 275 | 11 | EFO_0000694, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGTVDVADKLVTFGL | 1106 | Q9BXT4 | |
| EIAKVAISGGFQKLE | 1281 | Q13075 | |
| AASEGEQGLEKAVLA | 891 | Q5RHP9 | |
| DEAGLGKTVQIIAFF | 1116 | Q96L91 | |
| KDGVKFGEATVQVQV | 131 | A8MVZ5 | |
| SFDIVGDGVKDLLVG | 246 | Q8IWZ6 | |
| VKKNIDGTIEFSGEF | 1406 | Q99996 | |
| FSGEFGVKEETNIVK | 1416 | Q99996 | |
| ADGKSVFEVKGLETN | 966 | Q96N23 | |
| KLVSIGAEEIVDGNV | 106 | P12814 | |
| QKEIIDTNGAGDAFV | 306 | P55263 | |
| VRIGSGFDNIDIKSA | 96 | Q13363 | |
| QQGIVFLDEVDKIGS | 351 | O76031 | |
| VLVGTGTAAEAKLQE | 506 | Q9UBC3 | |
| IDVEGKIFQAAKGAG | 641 | Q9UBJ2 | |
| TAAGEIVEADVAIGK | 551 | Q9H0E9 | |
| FAEDVGSNKGAIIGL | 691 | P05067 | |
| FLGAVEEAKKEGGTV | 381 | P49419 | |
| VQLLTVKKDEGEGAA | 196 | Q02952 | |
| GAEVDLVDVKGQTAL | 101 | Q9Y576 | |
| EEQRAGSFVGKVSAV | 1111 | Q6V0I7 | |
| EQVKAAGALLTEGEA | 1261 | Q12802 | |
| LVSIGAEEIVDGNAK | 126 | O43707 | |
| LGNEKISAEAVGVDI | 146 | Q9C0F1 | |
| AEFVTRFGGNKVIEK | 106 | Q13085 | |
| GESEVKAQGFKAALV | 261 | Q9BZR8 | |
| TLLVEDFGVKGVQVE | 16 | Q92560 | |
| DFLANEAKGTKVVGA | 41 | P52209 | |
| IVSKIDGDKDGFVTV | 76 | O43852 | |
| SDAAVKEKAIQVGFV | 111 | Q92624 | |
| DGKIEGLTAEFVNLE | 31 | Q92688 | |
| VLTGDKQETAVNIGF | 761 | O60423 | |
| EKKAQALEIGDVVAG | 506 | A6NHC0 | |
| IEGVSQFSVKGDKEQ | 76 | P63098 | |
| GIAKKENGIDIIESA | 366 | Q9UPS8 | |
| KEFQATVEEGAVGVI | 366 | P55290 | |
| DIFNSDVVIVERGKG | 531 | Q13111 | |
| GIGDVETAVKFATQL | 121 | Q8N3C7 | |
| EIVGDFKSEKSNGEL | 746 | Q12830 | |
| FKEGKEVLVVNSQGE | 806 | Q12830 | |
| EEVLGKVLSAVGSAQ | 836 | Q9Y2H0 | |
| EAVVSFQGEALLGTK | 631 | Q5H9R4 | |
| GLIAVFTDVKQDNGD | 1061 | Q96BY7 | |
| QVKVVTLAIGDGAND | 791 | Q9Y2Q0 | |
| LTGDKKETAENIGFA | 731 | O43520 | |
| LDKSIQGGELFFTVV | 496 | O95803 | |
| KQFGIDGESFELKIV | 141 | Q9Y2P8 | |
| LQVKAFADKEEGGDV | 416 | P15918 | |
| GKDFQAIADVIGNKT | 306 | Q9P2K3 | |
| AVENGDAEKVASLLG | 26 | Q9P0K7 | |
| IGVDFKVKTISVDGN | 41 | Q9NP72 | |
| IGVDFKIQTIELDGK | 41 | Q92928 | |
| TVGIDFRNKVLDVDG | 96 | Q9ULW5 | |
| KIFVGGLSANTVVED | 111 | Q96DH6 | |
| VIEAVGDNASAFKKG | 76 | Q08257 | |
| TKGEAFSDGNIEVKL | 386 | Q96P65 | |
| VDGDGQLKAEEFILA | 291 | Q9NZM3 | |
| GSKVAGDIFKDNVVL | 101 | Q8N130 | |
| AQDGGALVASAKVVV | 321 | Q9Y5G8 | |
| INTLVEDKGKLFGVE | 106 | Q9Y5G5 | |
| VSLGFDQIVDEISGK | 36 | O75747 | |
| LALVKAGGFEIQEES | 151 | Q8IXQ6 | |
| DFIDEGVNIGLEVKS | 446 | P34897 | |
| ANVALFDGVVSKGDK | 271 | Q8N442 | |
| IIASDDGFKAVVGDA | 91 | P47929 | |
| INGIDFKGEAITFKA | 236 | Q9Y5P4 | |
| VKAALIEVGEGVNLS | 66 | Q86V59 | |
| VSFVKIEEVIGAGEF | 616 | P54762 | |
| EFISAVREGSLVNGK | 111 | Q9NVI1 | |
| GKVTNEFVSEEGKFL | 181 | Q6W4X9 | |
| AVILTKAVGGNEAAA | 121 | Q0GE19 | |
| VLDIEGNLEFGDISK | 576 | Q7Z5L7 | |
| VFENGKNTGEISVGI | 496 | M0R2J8 | |
| IDDGKLEVVAIFGSV | 961 | Q5KSL6 | |
| KIGVKFNVGTDDIAI | 151 | P58400 | |
| DQKVRAGESVELFGK | 1246 | Q15746 | |
| GDLVEILNGEKVKFD | 36 | Q8WZ60 | |
| ILNGEKVKFDDAGLS | 41 | Q8WZ60 | |
| LVFVIDGSKSLGEEN | 656 | O00339 | |
| DGSKSLGEENFEVVK | 661 | O00339 | |
| IAGFDSIDKKQGLQV | 1651 | Q86YW9 | |
| GVIFLKGNSATEEEI | 206 | P43366 | |
| FAQGLAVAGDVVSKV | 221 | O75487 | |
| VGVVKAFSANGKDII | 2666 | O95714 | |
| RGVKIGVKADDSQEA | 616 | Q9UQF2 | |
| DIVVAILGKNDIFGE | 796 | Q9NS40 | |
| IFKSIGADETVQGQG | 186 | Q76N89 | |
| QDFVRSAEVSGGLKI | 491 | P0C7T5 | |
| IEGKEGKQASLAADF | 891 | O43861 | |
| FSEADKIKVAQGVSG | 431 | P12268 | |
| NIVKLFAVEETGGSR | 66 | Q14164 | |
| FAVEETGGSRQKVLV | 71 | Q14164 | |
| IGKVIGDGNFAVVKE | 396 | Q8N568 | |
| GEEVGFVVDAKTAGK | 1631 | O75369 | |
| EGSEIGIVKAVAAQD | 2706 | Q9NYQ8 | |
| GLDKILEVVSDAAGQ | 56 | O95279 | |
| ASDKDKGVGVFNTVI | 276 | P47893 | |
| EELEKGSFVGNISKD | 41 | Q9Y5H3 | |
| DQNELVAKVFDGGVV | 436 | O00408 | |
| KEVDVGLAADVGTLQ | 196 | Q13011 | |
| FGATEVKELVLNGAD | 871 | Q5GLZ8 | |
| LETGQVGKSADFVVE | 581 | Q14315 | |
| KLDVQFAGTAKGEVV | 901 | Q14315 | |
| GIKVNQVSAAVGKDF | 1776 | Q5H8C1 | |
| EEVQTKAIIGLGFAF | 2186 | Q6KC79 | |
| ANVFITATGVVKLGD | 176 | Q9HC98 | |
| LAVKGVVFDVTSGKE | 66 | Q9UMX5 | |
| VAAEEKNGVVFIRGE | 526 | Q9UL01 | |
| KQKGADFLVTEVENG | 186 | P14618 | |
| GDVEIAEVNVKGLFV | 146 | Q8N9Z9 | |
| VETKNFSGAELEGLV | 431 | P46459 | |
| EKQEAKSGILEAAGF | 11 | P10070 | |
| VEGLRVFDKESNGTV | 136 | P12829 | |
| SGDGNDFIVVELVKG | 946 | Q9ULB1 | |
| KIGVKFNVGTDDIAI | 1186 | Q9ULB1 | |
| GTEENLDFKAIIDGV | 186 | P23471 | |
| IIDGVESVSRFGKQA | 196 | P23471 | |
| TGTLKIDFVGELNDK | 141 | A6NEC2 | |
| KASGVEGADVVKLLN | 176 | P19367 | |
| EIQKGVFEVKSTNGD | 256 | P38646 | |
| LEKAGTLGEQIFSIE | 351 | P17301 | |
| SVKGEEEVFLIGKNF | 456 | O94916 | |
| EAGKFEVNAKFLGVD | 1571 | Q86VI3 | |
| KILTGGADKNVVVFD | 236 | Q9UMS4 | |
| EVKVVAEGFDSANGI | 211 | Q15165 | |
| KEGVQITESGKFHVD | 546 | A1KZ92 | |
| GGNAVVELVTVKSFD | 256 | O75787 | |
| IQKAAGDIFDIVSGQ | 96 | A8MW95 | |
| GAAVSKGQVITFLDA | 196 | Q10472 | |
| KFTASAGIQVVGDDL | 306 | P06733 | |
| AVGDFQVEGKTKALL | 126 | Q15825 | |
| KFQVVAIEGLDATGK | 251 | Q5EBM0 | |
| KEVFDNKFHIIGAVG | 186 | P21926 | |
| EKGVQVLLTTVGAFA | 16 | Q8WXS5 | |
| VVEATAFGLGKEDAV | 596 | P07333 | |
| KDVFILGGTDDIQVL | 1046 | Q9C0G6 | |
| IKESGIQFSELEGQV | 521 | Q8NB78 | |
| QSFLIKVDGTGALDV | 211 | P0C671 | |
| KVDGGEVVKFLQDTL | 641 | Q14185 | |
| AEKQKGLAVEVGEDF | 101 | Q8N0S6 | |
| GLAVEVGEDFNIKVI | 106 | Q8N0S6 | |
| NVGVEVFSLGIKAAD | 266 | Q99715 | |
| EGVELFAIGIKNADE | 1326 | Q99715 | |
| KGELGILQDAEIEFF | 321 | Q9H227 | |
| TGFVKATEFGQVLKD | 1086 | Q5THR3 | |
| QGFQDETKKGSLEVA | 1906 | Q8TD26 | |
| NVFKIEDKIGEGTFS | 56 | O00311 | |
| LGVNVFAVGVKNADE | 306 | Q9P218 | |
| DFKEEKQAGVLGLNT | 336 | Q5T197 | |
| SAQGEGDDVKKLFTI | 1581 | Q8TD84 | |
| KLDVQFSGLTKGDAV | 906 | P21333 | |
| DAKDAGEGLLAVQIT | 1571 | P21333 | |
| GVELFAIGVKNADVN | 286 | Q05707 | |
| AQVLEDKGVGFGLVD | 96 | P31415 | |
| LQEIAGKEERVSFGQ | 586 | A8TX70 | |
| GADKTQIGVVQFSDK | 661 | A8TX70 | |
| ITIFAVGVGKANQKE | 946 | A8TX70 | |
| IGEFAVDKGTEVIIN | 381 | P05093 | |
| KRDVVFLIDGSQSAG | 1231 | P12111 | |
| NLFVKSAGSRIEDGV | 1526 | P12111 | |
| IAFVITGGKSVEDAQ | 1746 | P12111 | |
| NTVLSFFVKAVDGGI | 2671 | Q8TDW7 | |
| VFIGINDLEKEGAFV | 201 | Q9BWP8 | |
| QGDKITADGLQEVFE | 126 | P56937 | |
| FEEDIGGKKLTEIIN | 41 | P21695 | |
| VAVVQAILEGKGSFS | 326 | Q9ULV5 | |
| TSVIGDNDVKDLIGF | 481 | O43462 | |
| SEIDVALEGVKGAKN | 176 | Q9BUP0 | |
| FVGDEDLLEIIGNSK | 1631 | Q14204 | |
| IGNFEVGKEFDAILI | 386 | Q9Y2T3 | |
| KTGAEGAVLDEAKNI | 241 | Q12840 | |
| KDLSEFSVIVGNGEI | 556 | Q12840 | |
| GEKGVESFTQISKEA | 231 | Q14831 | |
| QAAFIGKETLKDESG | 106 | Q5JUW0 | |
| DGVKLTTQDGVIFKQ | 491 | Q86VF2 | |
| VNSDKGLKVGEVFTV | 246 | A8MVW5 | |
| EAGLKFATGDIIQII | 181 | Q00013 | |
| RAVAEGKADQFLVGT | 556 | Q9HC35 | |
| GELEQLKAGVAKVAS | 656 | Q9NT22 | |
| KDKDVGILVNNVGVF | 141 | Q3SXM5 | |
| IVDGDGLGIFKISVD | 301 | Q9ULB5 | |
| GAVELKKNEFQGELE | 61 | Q8NBJ4 | |
| AKDIQDVGAFSTVKG | 481 | Q15835 | |
| GASDGVDIQDVKFKL | 761 | Q14147 | |
| LEQAGKEADKAVQGF | 466 | Q6UWP8 | |
| GTKIAEKIDEFLATG | 66 | P06746 | |
| TGTLKIDFVGELNDK | 141 | P55786 | |
| NVLGDAFGTGIVEKL | 451 | P43005 | |
| AGEIIEIINKAGFTI | 106 | Q9Y5B8 | |
| GKGITFIFTDNEIKD | 3006 | Q8TE73 | |
| VFQDLEGVEKVFGVS | 376 | Q9UJX0 | |
| NGGLVEKEVLAASDA | 3226 | P98161 | |
| VFVVGGEENKLVAEA | 246 | P26022 | |
| VLVGALSESKEQEFG | 156 | Q9Y316 | |
| GQEGIVDIIKFDVTD | 1391 | P0C091 | |
| GFLTEVKNGEKDIQT | 301 | O95397 | |
| KGFSIAKEGVVGAVE | 6 | O76070 | |
| LEVAGTKAIVQVFEG | 81 | P15313 | |
| EGIKNLVDFLTGEEV | 151 | Q9H9J2 | |
| TFNVEAVGIGKGDAL | 16 | Q9BT43 | |
| QNESVSEIGGKIFEK | 526 | Q68CR1 | |
| ELAIAAIEKNGGVVT | 161 | Q9P015 | |
| VKGEDLDSQVGVIDF | 166 | Q8WXA3 | |
| VQVLVGAAESFGEKK | 541 | Q4G0N8 | |
| AVVGAVKSLQALGEV | 36 | Q9Y285 | |
| LGEAVDELNQKKEGF | 4726 | Q8NF91 | |
| DKEAKQLQEFVAEGG | 341 | A6NFQ2 | |
| KTGAEGAVLDEAKNI | 241 | O60282 | |
| DKSVENLDVLVGFGK | 611 | O14513 | |
| DIKDLKVGSVEEFQG | 856 | Q9HCE1 | |
| KDVAAIAGGLVDAEA | 336 | P28331 | |
| GDVKLADFGVAGQLT | 156 | Q9P289 | |
| SNKGDSLVIIEVFGV | 501 | Q86YW0 | |
| EFINKLTGEDVFGIT | 256 | Q9Y2Z4 | |
| GISKVFVGEVVEEAL | 156 | Q15544 | |
| AVSIGFAVNKKIEFG | 106 | P29218 | |
| AVAAGAKEVVIFGAA | 116 | P35914 | |
| GLQKTADFVEAIEGA | 916 | Q9Y6C5 | |
| GEVGDILTVVFKNNA | 816 | Q9BQS7 | |
| VDVSKFGVIFAGAQK | 186 | Q9Y617 | |
| KTVDNFVALATGEKG | 71 | P23284 | |
| DIEGTLGKGNFAVVK | 21 | Q9H0K1 | |
| GDEKGAAQVAAVLAQ | 186 | Q9H0F6 | |
| QEEGEKVVSLFVGVA | 191 | Q9BRY0 | |
| GKDSEIFTVNGILGE | 21 | Q9UIB8 | |
| VVFGLIDVSIGDFQK | 121 | Q86UG4 | |
| KDGIVTADIIGVANE | 2531 | Q9UKZ4 | |
| ASVIFEGVDIKNGTE | 146 | Q15738 | |
| KIEDGNDFGVAIQEK | 131 | Q9UL46 | |
| EVFGFEISKVGLVSA | 331 | Q9P2U7 | |
| ENVKRIDGVSEGKAA | 1196 | Q14191 | |
| KIDGIIDKTIIGDFQ | 91 | Q96A49 | |
| AVKLADFGLAIEVEG | 151 | Q9UQM7 | |
| GAFGEVAVVKLKNAD | 86 | Q5VT25 | |
| ASEVLGDFLGAVKNV | 176 | O43556 | |
| KCGDFKAVIVEVSGQ | 316 | Q96EM0 | |
| AQAAEELGVVAVGKT | 41 | Q0VD83 | |
| VTEGKFVDVNGIAIS | 136 | O75596 | |
| KQTAALGALKEEVGD | 76 | Q6UXB4 | |
| EVAAADVKQLGGSVE | 46 | Q96KP4 | |
| KEGKLAVVADDGVTQ | 516 | P29973 | |
| VGEFSGANKEKLEAT | 86 | P10599 | |
| LVSGGVAEEAKQALK | 46 | P52758 | |
| IGFDIIATTGEEAKN | 266 | Q8TBB6 | |
| LGFKAGDVIQVLEAS | 166 | Q96N96 | |
| SVDIGEEVLKKGFAE | 196 | Q9BXU1 | |
| AAAVGGVASQEVLKA | 391 | A0AVT1 | |
| GVASQEVLKAVTGKF | 396 | A0AVT1 | |
| QDFEGRVIVATSKGV | 291 | Q8WUH2 | |
| SLGGFSIEDVQKEIK | 61 | Q8IWS0 | |
| KEAEAALGGLVNAVF | 141 | Q7Z2Z1 | |
| IVFIEEQAAGIGKSA | 66 | Q86VN1 | |
| SQEKIGVKGELFQED | 421 | Q9BVS5 | |
| VLDVAFVLEGSDKIG | 1496 | P04275 | |
| FFQVDGLKVTKDLGA | 1826 | Q99973 | |
| SINQVFGEGTEAVKK | 711 | Q13009 | |
| VGKRNDTGVFVSDIV | 1741 | O75970 | |
| FGEIVDIDIKKVNGV | 461 | Q96T58 | |
| GATKEQSFKIGQEIA | 2791 | O60673 | |
| FVGLNEDKEVIGFKA | 256 | Q6IEE8 | |
| TGDFLIEVNGVNVVK | 626 | Q9BYB0 | |
| AFKVVVQEEGGSGLS | 581 | Q8NE28 | |
| DKIVAVDGVNIQGFA | 416 | Q8NI35 | |
| GVFISDIVKGGAADL | 1556 | Q8NI35 | |
| IKSVDGFQGREKEAV | 561 | P38935 | |
| VEAKFVQDTLKGDGV | 146 | O43617 | |
| GAQVDQSVFEELIKG | 631 | O95759 | |
| DFSQQDIDGLEVVGK | 346 | Q8TBZ2 | |
| LGKQDGVAAFEVDVI | 141 | Q9Y5W5 | |
| KKGFSEADNVVSGEI | 721 | P47989 | |
| VQATFILKDAFAGGV | 251 | O15040 | |
| GDADVDVSAVQAKLG | 806 | Q9Y2I9 | |
| GDIKSSNVVIKGDFE | 166 | Q96KB5 | |
| DKIQGFQAKGEADIL | 161 | Q12899 | |
| GSVAVQDADIEKRKG | 1396 | Q9UGU0 | |
| QEKAFGAAGETIVIE | 176 | P22102 | |
| QESGVAQTLKKGEVF | 611 | Q8N392 | |
| DDVVVKTKFVGGIAQ | 2486 | Q9Y4G6 | |
| DVKLNLGGDFIKEST | 36 | Q9BSR8 | |
| GVSAVALLVGEKVQE | 46 | Q9NZ63 | |
| GQVIEADAFGIDKTA | 846 | P35968 | |
| GLFNQDKEVGAIKLE | 41 | Q9ULL1 | |
| EGAKAAGAVISAVVD | 256 | Q96KN8 | |
| INGKTGLEKEQEFIS | 1126 | Q70CQ2 | |
| GGLVDESIQKKVTFQ | 231 | Q6PF06 | |
| TGDVDGAQIVFKEVQ | 401 | Q8N584 | |
| QAAFIGKETLKDESG | 106 | Q2M3X9 | |
| VVQKGGEAEKQTAEF | 461 | Q6NT04 | |
| LLKFGADVNVSGEVG | 186 | Q59H18 | |
| FLGGAAAQEVIKIIT | 496 | Q13564 | |
| VALASGGEVIFTKDQ | 471 | Q9Y334 | |
| FLAKAQGLEEGVAET | 811 | Q13308 | |
| QGVNEGVDFSKDLLK | 711 | Q9NYI0 | |
| AGAVGSKEELEVDFK | 236 | Q9UGI0 | |
| KGEEQIGFELVEKLF | 416 | O94782 | |
| VSGLINQGKVEAFEK | 176 | Q9Y487 | |
| IQGKQFEGLVDTEAD | 16 | P63124 | |
| GANIASGEEVAIKLE | 26 | P49674 | |
| KGKDVNLAEFAVAAG | 381 | Q9BRK3 | |
| EGGVKLVDFGVSAQL | 161 | Q8NEV4 | |
| TEGGVKLVDFGVSAQ | 166 | Q8WXR4 | |
| LAAAEKFKVQGEAVS | 136 | Q9BZK3 |